Note 1. Basis of presentation and summary of significant accounting policies
\n\u00a0
\nThe accompanying unaudited\u00a0interim consolidated financial statements reflect the accounts of the Company for the quarterly period ended August 31, 2025\u00a0(the \u201cFinancial Statements\u201d). The Financial Statements were prepared in accordance with generally accepted accounting principles in the United States of America (\u201cU.S. GAAP\u201d) for interim financial information and pursuant to the rules and regulations of the United States Securities and Exchange Commission (\u201cSEC\u201d) for interim financial information. Accordingly, they do not include all of the information and notes required by U.S. GAAP and should be read in conjunction with the audited consolidated financial statements (the \u201cAnnual Financial Statements\u201d) included in the Company\u2019s Annual Report on Form 10-K for the fiscal year ended\u00a0 May 31, 2025\u00a0(the \u201cAnnual Report\u201d). These\u00a0Financial Statements reflect all adjustments, which, in the opinion of management, are necessary for a fair presentation of the results for the interim periods presented. Interim results are not necessarily indicative of results for a full fiscal year.\u00a0
\n\u00a0
\nThese Financial Statements have been prepared on a\u00a0going concern basis, which assumes that the Company will continue in operation for the foreseeable future and, accordingly, will be able to realize its assets and discharge its liabilities in the normal course of operations as they come due, under the historical cost convention except for certain financial instruments that are measured at fair value, as detailed in the Company\u2019s accounting policies.
\n\u00a0
\nAll amounts in the Financial Statements, and the accompanying notes and tables have been rounded to the nearest thousand, except par values and per share amounts, and unless otherwise indicated.
\n\u00a0
\nBasis of consolidation
\n\u00a0
\nSubsidiaries are entities controlled by the Company. Control exists when the Company either has a controlling voting interest or is the primary beneficiary of a variable interest entity. The financial statements of all subsidiaries are included in the Financial Statements from the date that control commences until the date that control ceases. All intercompany balances and transactions have been eliminated on consolidation. A complete list of our subsidiaries that existed as of our most recent fiscal year end is included in the Annual Report.
\n\u00a0
\n \n \nEarnings (loss) per share
\n\u00a0
\nBasic earnings (loss) per share is computed by dividing reported net income (loss) attributable to stockholders of Tilray Brands, Inc. by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed by dividing reported net income (loss) attributable to stockholders of Tilray Brands, Inc. by the sum of the weighted average number of common shares and the number of dilutive potential common share equivalents outstanding during the period. Potential dilutive common share equivalents consist of the incremental common shares issuable upon the exercise of vested share options, warrants, and RSUs and the incremental shares issuable upon conversion of the convertible debentures and similar instruments. Shares of Common Stock outstanding under the\u00a0share lending\u00a0arrangement entered into in conjunction with the TLRY\u00a027 Notes, see Note\u00a012\u00a0(Convertible debentures payable) are excluded from the calculation of basic and diluted earnings per share\u00a0because the borrower of the shares is required under the share lending arrangement to refund any dividends paid on the shares lent.\u00a0
\n\u00a0
\nIn computing diluted earnings (loss) per share, common share equivalents are not considered in periods in which a net loss attributable to Tilray shareholders is reported, as the inclusion of the common share equivalents would be anti-dilutive. For the three months\u00a0ended\u00a0 August 31, 2025 and\u00a0 August 31, 2024, the dilutive potential common share equivalents outstanding consisted of the following: 52,107,218 and 23,411,577 common shares from RSUs, 3,032,011 and 3,359,144 common shares from share options, 6,209,000 and 6,209,000 common shares for warrants and 37,664,780 and 64,971,746 common shares for convertible debentures, respectively.
\n\u00a0
\nNew accounting pronouncements\u00a0not\u00a0yet adopted
\n\u00a0
\nIn\u00a0 August 2023,\u00a0the Financial Accounting Standards Board (\u201cFASB\u201d) issued Accounting Standards Update (\u201cASU\u201d)\u00a02023-05,\u00a0Business Combination - Joint Venture Formations\u00a0(Subtopic\u00a0805-60) Recognition and Initial Measurement (\u201cASU\u00a02023-05\u201d), which is intended to address the accounting for contributions made to a joint venture. ASU\u00a02023-05\u00a0is effective for the Company beginning\u00a0\u00a0 June 1, 2026.\u00a0This update will be applied prospectively and the Company is currently evaluating the effect of adopting this ASU.
\n\u00a0
\nIn October\u00a02023,\u00a0the FASB issued ASU\u00a02023-06,\u00a0Disclosure Improvements: Codification Amendments in Response to the SEC\u2019s Disclosure Update and Simplification Initiative,\u00a0which amends the disclosure or presentation requirements related to various subtopics in the FASB Accounting Standards Codification (the \u201cCodification\u201d). The effective date for each amendment will be the date on which the SEC\u2019s removal of that related disclosure from Regulation S-X\u00a0or Regulation S-K becomes effective, with early adoption prohibited. If by June 30, 2027,\u00a0the SEC has\u00a0not\u00a0removed the applicable requirement from Regulation S-X\u00a0or Regulation S-K, the pending content of the related amendment will be removed from the Codification and will\u00a0not\u00a0become effective for any entity.\u00a0The Company is currently evaluating the effect of adopting this ASU.\u00a0
\n\u00a0
\nIn December 2023,\u00a0the FASB issued ASU\u00a02023-09,\u00a0Income Taxes (Topic\u00a0740)\u00a0Improvements to Income Tax Disclosures,\u00a0which requires public entities to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold on an annual basis. ASU\u00a02023-09\u00a0is effective for the Company beginning with its\u00a0fiscal year ended\u00a0 May 31, 2026\u00a0and will be disclosed\u00a0in the Financial\u00a0Statements reported in our Annual Report on Form\u00a010-K filed with the SEC for such period.\u00a0The Company is in the process of evaluating the impact of the financial statement disclosure requirement.
\n\u00a0
\nIn November 2024,\u00a0the FASB issued ASU\u00a02024-03,\u00a0Income Statement\u2014Reporting Comprehensive Income\u2014Expense Disaggregation Disclosures (Subtopic\u00a0220-40): Disaggregation of Income Statement Expenses,\u00a0which requires disaggregated disclosure of income statement expenses for public business entities. ASU\u00a02024-03\u00a0is effective for the Company beginning\u00a0 June 1, 2026.\u00a0The Company is currently evaluating the effect of adopting this ASU.
\n\u00a0
\nNew accounting pronouncements recently adopted
\n\u00a0
\nIn\u00a0 November 2024,\u00a0the FASB issued ASU\u00a02024-04,\u00a0Debt with Conversion and Other Options (Subtopic\u00a0470-20): Induced Conversions of Convertible Debt Instruments,\u00a0which seeks to clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. The Company adopted ASU\u00a02024-04\u00a0beginning\u00a0 June 1, 2025,\u00a0however, it\u00a0did\u00a0not\u00a0have any impact on our unaudited\u00a0interim consolidated financial statements.
\n\u00a0
\nDigital Assets
\n\u00a0
\nIn December 2023, FASB issued ASU\u00a02023-08,\u00a0Intangibles\u2014Goodwill and Other\u2014Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets. ASU 2023-08 requires certain crypto assets to be measured at fair value separately on the balance sheet with gains and losses from changes in the fair value reported as unrealized gains or losses in the consolidated statement of\u00a0income (loss) and comprehensive income (loss) each reporting period. ASU 2023-08 also enhances the other intangible asset disclosure requirements by requiring the name, cost basis, fair value, and number of units for each significant crypto asset holding.\u00a0In conjunction with the acquisition of digital assets during the fiscal quarter ended August 31, 2025, the Company adopted and applied ASU-2023-08 henceforth.\u00a0
\n\u00a0
\nThe Company's digital assets are initially recorded at cost, and are subsequently measured at fair value as of each reporting period. The Company determines the fair value of its digital assets in accordance with ASC 820,\u00a0Fair Value Measurement, based on quoted prices in\u00a0its principal market for Bitcoin (Level 1). Changes in fair value are recognized as incurred in the Company's consolidated statement of income (loss) and comprehensive income (loss), as \u201cUnrealized (gain) loss on digital assets,\u201d within\u00a0non-operating (income) and expenses, net.\u00a0
\n\u00a0
\n \n \n "}]},{"name":"rpt:f-516","factDimensions":{"xbrl:concept":"us-gaap:ConsolidationPolicyTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":"Basis of consolidation
\n\u00a0
\nSubsidiaries are entities controlled by the Company. Control exists when the Company either has a controlling voting interest or is the primary beneficiary of a variable interest entity. The financial statements of all subsidiaries are included in the Financial Statements from the date that control commences until the date that control ceases. All intercompany balances and transactions have been eliminated on consolidation. A complete list of our subsidiaries that existed as of our most recent fiscal year end is included in the Annual Report.
\n\u00a0
"}]},{"name":"rpt:f-517","factDimensions":{"xbrl:concept":"us-gaap:EarningsPerSharePolicyTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":"Earnings (loss) per share
\n\u00a0
\nBasic earnings (loss) per share is computed by dividing reported net income (loss) attributable to stockholders of Tilray Brands, Inc. by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed by dividing reported net income (loss) attributable to stockholders of Tilray Brands, Inc. by the sum of the weighted average number of common shares and the number of dilutive potential common share equivalents outstanding during the period. Potential dilutive common share equivalents consist of the incremental common shares issuable upon the exercise of vested share options, warrants, and RSUs and the incremental shares issuable upon conversion of the convertible debentures and similar instruments. Shares of Common Stock outstanding under the\u00a0share lending\u00a0arrangement entered into in conjunction with the TLRY\u00a027 Notes, see Note\u00a012\u00a0(Convertible debentures payable) are excluded from the calculation of basic and diluted earnings per share\u00a0because the borrower of the shares is required under the share lending arrangement to refund any dividends paid on the shares lent.\u00a0
\n\u00a0
\nIn computing diluted earnings (loss) per share, common share equivalents are not considered in periods in which a net loss attributable to Tilray shareholders is reported, as the inclusion of the common share equivalents would be anti-dilutive. For the three months\u00a0ended\u00a0 August 31, 2025 and\u00a0 August 31, 2024, the dilutive potential common share equivalents outstanding consisted of the following: 52,107,218 and 23,411,577 common shares from RSUs, 3,032,011 and 3,359,144 common shares from share options, 6,209,000 and 6,209,000 common shares for warrants and 37,664,780 and 64,971,746 common shares for convertible debentures, respectively.
\n\u00a0
"}]},{"name":"rpt:f-518","factDimensions":{"xbrl:concept":"us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:RestrictedStockUnitsRSUMember"},"factValues":[{"value":"52107218"}]},{"name":"rpt:f-519","factDimensions":{"xbrl:concept":"us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants","xbrl:period":"2024-06-01T00:00:00/2024-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:RestrictedStockUnitsRSUMember"},"factValues":[{"value":"23411577"}]},{"name":"rpt:f-520","factDimensions":{"xbrl:concept":"us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember"},"factValues":[{"value":"3032011"}]},{"name":"rpt:f-521","factDimensions":{"xbrl:concept":"us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants","xbrl:period":"2024-06-01T00:00:00/2024-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember"},"factValues":[{"value":"3359144"}]},{"name":"rpt:f-522","factDimensions":{"xbrl:concept":"us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares","us-gaap:AwardTypeAxis":"tlry:WarrantsMember"},"factValues":[{"value":"6209000"}]},{"name":"rpt:f-523","factDimensions":{"xbrl:concept":"us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants","xbrl:period":"2024-06-01T00:00:00/2024-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares","us-gaap:AwardTypeAxis":"tlry:WarrantsMember"},"factValues":[{"value":"6209000"}]},{"name":"rpt:f-524","factDimensions":{"xbrl:concept":"us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"37664780"}]},{"name":"rpt:f-525","factDimensions":{"xbrl:concept":"us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities","xbrl:period":"2024-06-01T00:00:00/2024-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"64971746"}]},{"name":"rpt:f-526","factDimensions":{"xbrl:concept":"us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":"New accounting pronouncements\u00a0not\u00a0yet adopted
\n\u00a0
\nIn\u00a0 August 2023,\u00a0the Financial Accounting Standards Board (\u201cFASB\u201d) issued Accounting Standards Update (\u201cASU\u201d)\u00a02023-05,\u00a0Business Combination - Joint Venture Formations\u00a0(Subtopic\u00a0805-60) Recognition and Initial Measurement (\u201cASU\u00a02023-05\u201d), which is intended to address the accounting for contributions made to a joint venture. ASU\u00a02023-05\u00a0is effective for the Company beginning\u00a0\u00a0 June 1, 2026.\u00a0This update will be applied prospectively and the Company is currently evaluating the effect of adopting this ASU.
\n\u00a0
\nIn October\u00a02023,\u00a0the FASB issued ASU\u00a02023-06,\u00a0Disclosure Improvements: Codification Amendments in Response to the SEC\u2019s Disclosure Update and Simplification Initiative,\u00a0which amends the disclosure or presentation requirements related to various subtopics in the FASB Accounting Standards Codification (the \u201cCodification\u201d). The effective date for each amendment will be the date on which the SEC\u2019s removal of that related disclosure from Regulation S-X\u00a0or Regulation S-K becomes effective, with early adoption prohibited. If by June 30, 2027,\u00a0the SEC has\u00a0not\u00a0removed the applicable requirement from Regulation S-X\u00a0or Regulation S-K, the pending content of the related amendment will be removed from the Codification and will\u00a0not\u00a0become effective for any entity.\u00a0The Company is currently evaluating the effect of adopting this ASU.\u00a0
\n\u00a0
\nIn December 2023,\u00a0the FASB issued ASU\u00a02023-09,\u00a0Income Taxes (Topic\u00a0740)\u00a0Improvements to Income Tax Disclosures,\u00a0which requires public entities to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold on an annual basis. ASU\u00a02023-09\u00a0is effective for the Company beginning with its\u00a0fiscal year ended\u00a0 May 31, 2026\u00a0and will be disclosed\u00a0in the Financial\u00a0Statements reported in our Annual Report on Form\u00a010-K filed with the SEC for such period.\u00a0The Company is in the process of evaluating the impact of the financial statement disclosure requirement.
\n\u00a0
\nIn November 2024,\u00a0the FASB issued ASU\u00a02024-03,\u00a0Income Statement\u2014Reporting Comprehensive Income\u2014Expense Disaggregation Disclosures (Subtopic\u00a0220-40): Disaggregation of Income Statement Expenses,\u00a0which requires disaggregated disclosure of income statement expenses for public business entities. ASU\u00a02024-03\u00a0is effective for the Company beginning\u00a0 June 1, 2026.\u00a0The Company is currently evaluating the effect of adopting this ASU.
\n\u00a0
\nNew accounting pronouncements recently adopted
\n\u00a0
\nIn\u00a0 November 2024,\u00a0the FASB issued ASU\u00a02024-04,\u00a0Debt with Conversion and Other Options (Subtopic\u00a0470-20): Induced Conversions of Convertible Debt Instruments,\u00a0which seeks to clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. The Company adopted ASU\u00a02024-04\u00a0beginning\u00a0 June 1, 2025,\u00a0however, it\u00a0did\u00a0not\u00a0have any impact on our unaudited\u00a0interim consolidated financial statements.
\n\u00a0
"}]},{"name":"rpt:f-527","factDimensions":{"xbrl:concept":"srt:PlatformOperatorCryptoAssetPolicyTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":"Digital Assets
\n\u00a0
\nIn December 2023, FASB issued ASU\u00a02023-08,\u00a0Intangibles\u2014Goodwill and Other\u2014Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets. ASU 2023-08 requires certain crypto assets to be measured at fair value separately on the balance sheet with gains and losses from changes in the fair value reported as unrealized gains or losses in the consolidated statement of\u00a0income (loss) and comprehensive income (loss) each reporting period. ASU 2023-08 also enhances the other intangible asset disclosure requirements by requiring the name, cost basis, fair value, and number of units for each significant crypto asset holding.\u00a0In conjunction with the acquisition of digital assets during the fiscal quarter ended August 31, 2025, the Company adopted and applied ASU-2023-08 henceforth.\u00a0
\n\u00a0
\nThe Company's digital assets are initially recorded at cost, and are subsequently measured at fair value as of each reporting period. The Company determines the fair value of its digital assets in accordance with ASC 820,\u00a0Fair Value Measurement, based on quoted prices in\u00a0its principal market for Bitcoin (Level 1). Changes in fair value are recognized as incurred in the Company's consolidated statement of income (loss) and comprehensive income (loss), as \u201cUnrealized (gain) loss on digital assets,\u201d within\u00a0non-operating (income) and expenses, net.\u00a0
\n\u00a0
\n "}]},{"name":"rpt:f-528","factDimensions":{"xbrl:concept":"us-gaap:InventoryDisclosureTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \nNote 2. Inventory
\n\u00a0
\nInventory consisted of the following:
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \nAugust 31, | \n\u00a0 | \n\u00a0 | \nMay 31, | \n\u00a0 | \n||
| \u00a0 | \n\u00a0 | \n2025 | \n\u00a0 | \n\u00a0 | \n2025 | \n\u00a0 | \n||
| Beverage inventory | \n \u00a0 | \n$ | \n70,622 | \n\u00a0 | \n\u00a0 | \n$ | \n63,965 | \n\u00a0 | \n
| Cannabis plants | \n \u00a0 | \n\u00a0 | \n27,033 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n24,045 | \n\u00a0 | \n
| Dried cannabis | \n \u00a0 | \n\u00a0 | \n106,653 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n103,507 | \n\u00a0 | \n
| Cannabis derivatives | \n \u00a0 | \n\u00a0 | \n4,481 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n7,877 | \n\u00a0 | \n
| Cannabis vapes | \n \u00a0 | \n\u00a0 | \n1,892 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n1,860 | \n\u00a0 | \n
| Packaging and other inventory items | \n \u00a0 | \n\u00a0 | \n14,508 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n15,366 | \n\u00a0 | \n
| Distribution inventory | \n \u00a0 | \n\u00a0 | \n44,450 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n38,735 | \n\u00a0 | \n
| Wellness inventory | \n \u00a0 | \n\u00a0 | \n13,148 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n15,527 | \n\u00a0 | \n
| Total | \n \u00a0 | \n$ | \n282,787 | \n\u00a0 | \n\u00a0 | \n$ | \n270,882 | \n\u00a0 | \n
\u00a0\u00a0
\n "}]},{"name":"rpt:f-529","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfInventoryCurrentTableTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n| \u00a0 | \n\u00a0 | \nAugust 31, | \n\u00a0 | \n\u00a0 | \nMay 31, | \n\u00a0 | \n||
| \u00a0 | \n\u00a0 | \n2025 | \n\u00a0 | \n\u00a0 | \n2025 | \n\u00a0 | \n||
| Beverage inventory | \n \u00a0 | \n$ | \n70,622 | \n\u00a0 | \n\u00a0 | \n$ | \n63,965 | \n\u00a0 | \n
| Cannabis plants | \n \u00a0 | \n\u00a0 | \n27,033 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n24,045 | \n\u00a0 | \n
| Dried cannabis | \n \u00a0 | \n\u00a0 | \n106,653 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n103,507 | \n\u00a0 | \n
| Cannabis derivatives | \n \u00a0 | \n\u00a0 | \n4,481 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n7,877 | \n\u00a0 | \n
| Cannabis vapes | \n \u00a0 | \n\u00a0 | \n1,892 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n1,860 | \n\u00a0 | \n
| Packaging and other inventory items | \n \u00a0 | \n\u00a0 | \n14,508 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n15,366 | \n\u00a0 | \n
| Distribution inventory | \n \u00a0 | \n\u00a0 | \n44,450 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n38,735 | \n\u00a0 | \n
| Wellness inventory | \n \u00a0 | \n\u00a0 | \n13,148 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n15,527 | \n\u00a0 | \n
| Total | \n \u00a0 | \n$ | \n282,787 | \n\u00a0 | \n\u00a0 | \n$ | \n270,882 | \n\u00a0 | \n
Note 3. Capital assets
\n\u00a0
\nCapital assets consisted of the following:
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \nAugust 31, | \n\u00a0 | \n\u00a0 | \nMay 31, | \n\u00a0 | \n||
| \u00a0 | \n\u00a0 | \n2025 | \n\u00a0 | \n\u00a0 | \n2025 | \n\u00a0 | \n||
| Land | \n \u00a0 | \n$ | \n45,122 | \n\u00a0 | \n\u00a0 | \n$ | \n44,529 | \n\u00a0 | \n
| Production facilities | \n \u00a0 | \n\u00a0 | \n416,605 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n407,650 | \n\u00a0 | \n
| Equipment | \n \u00a0 | \n\u00a0 | \n278,584 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n280,585 | \n\u00a0 | \n
| Leasehold improvements | \n \u00a0 | \n\u00a0 | \n20,415 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n20,415 | \n\u00a0 | \n
| Finance lease, right-of-use assets | \n \u00a0 | \n\u00a0 | \n40,019 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n40,308 | \n\u00a0 | \n
| Construction in progress | \n \u00a0 | \n\u00a0 | \n11,190 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n11,241 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n$ | \n811,935 | \n\u00a0 | \n\u00a0 | \n$ | \n804,728 | \n\u00a0 | \n
| Less: accumulated amortization | \n \u00a0 | \n\u00a0 | \n(251,778 | \n) | \n\u00a0 | \n\u00a0 | \n(236,295 | \n) | \n
| Total | \n \u00a0 | \n$ | \n560,157 | \n\u00a0 | \n\u00a0 | \n$ | \n568,433 | \n\u00a0 | \n
\u00a0 \u00a0\u00a0
\nAssets held for sale\u00a0consisted of the following:
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n\u00a0 | \n May 31, | \n \u00a0 | \n||
| \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n||
| Production facilities | \n \u00a0 | \n$ | \n5,800 | \n\u00a0 | \n\u00a0 | \n$ | \n5,800 | \n\u00a0 | \n
| Total | \n \u00a0 | \n$ | \n5,800 | \n\u00a0 | \n\u00a0 | \n$ | \n5,800 | \n\u00a0 | \n
\u00a0
\nAs of August 31, 2025, the Company classified the Fort Collins, CO partially vacant warehouse facility from its Cannabis reporting segment as held for sale. The Company expects the sale of the asset to be completed during the fiscal year ended May 31, 2026.\u00a0
\n\u00a0
\n \n \n "}]},{"name":"rpt:f-549","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n| \u00a0 | \n\u00a0 | \nAugust 31, | \n\u00a0 | \n\u00a0 | \nMay 31, | \n\u00a0 | \n||
| \u00a0 | \n\u00a0 | \n2025 | \n\u00a0 | \n\u00a0 | \n2025 | \n\u00a0 | \n||
| Land | \n \u00a0 | \n$ | \n45,122 | \n\u00a0 | \n\u00a0 | \n$ | \n44,529 | \n\u00a0 | \n
| Production facilities | \n \u00a0 | \n\u00a0 | \n416,605 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n407,650 | \n\u00a0 | \n
| Equipment | \n \u00a0 | \n\u00a0 | \n278,584 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n280,585 | \n\u00a0 | \n
| Leasehold improvements | \n \u00a0 | \n\u00a0 | \n20,415 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n20,415 | \n\u00a0 | \n
| Finance lease, right-of-use assets | \n \u00a0 | \n\u00a0 | \n40,019 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n40,308 | \n\u00a0 | \n
| Construction in progress | \n \u00a0 | \n\u00a0 | \n11,190 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n11,241 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n$ | \n811,935 | \n\u00a0 | \n\u00a0 | \n$ | \n804,728 | \n\u00a0 | \n
| Less: accumulated amortization | \n \u00a0 | \n\u00a0 | \n(251,778 | \n) | \n\u00a0 | \n\u00a0 | \n(236,295 | \n) | \n
| Total | \n \u00a0 | \n$ | \n560,157 | \n\u00a0 | \n\u00a0 | \n$ | \n568,433 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n\u00a0 | \n May 31, | \n \u00a0 | \n||
| \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n||
| Production facilities | \n \u00a0 | \n$ | \n5,800 | \n\u00a0 | \n\u00a0 | \n$ | \n5,800 | \n\u00a0 | \n
| Total | \n \u00a0 | \n$ | \n5,800 | \n\u00a0 | \n\u00a0 | \n$ | \n5,800 | \n\u00a0 | \n
Note 4. Leases
\n\u00a0
\nThe table below presents the lease-related assets and liabilities recorded on the balance sheet.
\n\u00a0
\n \n| \u00a0 | \u00a0 | \u00a0 | August 31, | \u00a0 | \u00a0 | May 31, | \u00a0 | ||
| \u00a0 | Classification on Balance Sheet | \u00a0 | 2025 | \u00a0 | \u00a0 | 2025 | \u00a0 | ||
| Assets | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Finance lease, right-of-use assets | Capital assets | \u00a0 | $ | 40,019 | \u00a0 | \u00a0 | $ | 40,308 | \u00a0 |
| Operating lease, right-of-use assets | Operating lease, right-of-use assets | \u00a0 | \u00a0 | 21,003 | \u00a0 | \u00a0 | \u00a0 | 22,279 | \u00a0 |
| Total right-of-use assets | \u00a0 | $ | 61,022 | \u00a0 | \u00a0 | $ | 62,587 | \u00a0 | |
| Liabilities | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Current: | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Current portion of finance lease liabilities | Current portion of liabilities | \u00a0 | $ | 1,582 | \u00a0 | \u00a0 | $ | 1,560 | \u00a0 |
| Current portion of operating lease liabilities | Current portion of liabilities | \u00a0 | \u00a0 | 5,895 | \u00a0 | \u00a0 | \u00a0 | 5,381 | \u00a0 |
| Non-current: | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Finance lease liabilities | Lease | \u00a0 | \u00a0 | 43,965 | \u00a0 | \u00a0 | \u00a0 | 44,295 | \u00a0 |
| Operating lease liabilities | Lease | \u00a0 | \u00a0 | 19,380 | \u00a0 | \u00a0 | \u00a0 | 20,630 | \u00a0 |
| Total lease liabilities | \u00a0 | $ | 70,822 | \u00a0 | \u00a0 | $ | 71,866 | \u00a0 |
\u00a0
\nThe following table presents the future undiscounted payments associated with lease liabilities as of August 31, 2025:
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \n Operating | \n \u00a0 | \n\u00a0 | \n Finance | \n \u00a0 | \n||
| \u00a0 | \n\u00a0 | \nleases | \n\u00a0 | \n\u00a0 | \nleases | \n\u00a0 | \n||
| 2026 (remaining nine months) | \n \u00a0 | \n$ | \n5,902 | \n\u00a0 | \n\u00a0 | \n$ | \n3,388 | \n\u00a0 | \n
| 2027 | \n \u00a0 | \n\u00a0 | \n6,931 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n4,518 | \n\u00a0 | \n
| 2028 | \n \u00a0 | \n\u00a0 | \n5,916 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n4,518 | \n\u00a0 | \n
| 2029 | \n \u00a0 | \n\u00a0 | \n2,941 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n4,370 | \n\u00a0 | \n
| Thereafter | \n \u00a0 | \n\u00a0 | \n10,647 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n66,694 | \n\u00a0 | \n
| Total minimum lease payments | \n \u00a0 | \n$ | \n32,337 | \n\u00a0 | \n\u00a0 | \n$ | \n83,488 | \n\u00a0 | \n
| Imputed interest | \n \u00a0 | \n\u00a0 | \n(7,062 | \n) | \n\u00a0 | \n\u00a0 | \n(37,941 | \n) | \n
| Obligations recognized | \n \u00a0 | \n$ | \n25,275 | \n\u00a0 | \n\u00a0 | \n$ | \n45,547 | \n\u00a0 | \n
\u00a0
\n "}]},{"name":"rpt:f-574","factDimensions":{"xbrl:concept":"tlry:LeaseRelatedAssetsAndLiabilitiesTableTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n| \u00a0 | \u00a0 | \u00a0 | August 31, | \u00a0 | \u00a0 | May 31, | \u00a0 | ||
| \u00a0 | Classification on Balance Sheet | \u00a0 | 2025 | \u00a0 | \u00a0 | 2025 | \u00a0 | ||
| Assets | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Finance lease, right-of-use assets | Capital assets | \u00a0 | $ | 40,019 | \u00a0 | \u00a0 | $ | 40,308 | \u00a0 |
| Operating lease, right-of-use assets | Operating lease, right-of-use assets | \u00a0 | \u00a0 | 21,003 | \u00a0 | \u00a0 | \u00a0 | 22,279 | \u00a0 |
| Total right-of-use assets | \u00a0 | $ | 61,022 | \u00a0 | \u00a0 | $ | 62,587 | \u00a0 | |
| Liabilities | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Current: | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Current portion of finance lease liabilities | Current portion of liabilities | \u00a0 | $ | 1,582 | \u00a0 | \u00a0 | $ | 1,560 | \u00a0 |
| Current portion of operating lease liabilities | Current portion of liabilities | \u00a0 | \u00a0 | 5,895 | \u00a0 | \u00a0 | \u00a0 | 5,381 | \u00a0 |
| Non-current: | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Finance lease liabilities | Lease | \u00a0 | \u00a0 | 43,965 | \u00a0 | \u00a0 | \u00a0 | 44,295 | \u00a0 |
| Operating lease liabilities | Lease | \u00a0 | \u00a0 | 19,380 | \u00a0 | \u00a0 | \u00a0 | 20,630 | \u00a0 |
| Total lease liabilities | \u00a0 | $ | 70,822 | \u00a0 | \u00a0 | $ | 71,866 | \u00a0 |
| \u00a0 | \n\u00a0 | \n Operating | \n \u00a0 | \n\u00a0 | \n Finance | \n \u00a0 | \n||
| \u00a0 | \n\u00a0 | \nleases | \n\u00a0 | \n\u00a0 | \nleases | \n\u00a0 | \n||
| 2026 (remaining nine months) | \n \u00a0 | \n$ | \n5,902 | \n\u00a0 | \n\u00a0 | \n$ | \n3,388 | \n\u00a0 | \n
| 2027 | \n \u00a0 | \n\u00a0 | \n6,931 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n4,518 | \n\u00a0 | \n
| 2028 | \n \u00a0 | \n\u00a0 | \n5,916 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n4,518 | \n\u00a0 | \n
| 2029 | \n \u00a0 | \n\u00a0 | \n2,941 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n4,370 | \n\u00a0 | \n
| Thereafter | \n \u00a0 | \n\u00a0 | \n10,647 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n66,694 | \n\u00a0 | \n
| Total minimum lease payments | \n \u00a0 | \n$ | \n32,337 | \n\u00a0 | \n\u00a0 | \n$ | \n83,488 | \n\u00a0 | \n
| Imputed interest | \n \u00a0 | \n\u00a0 | \n(7,062 | \n) | \n\u00a0 | \n\u00a0 | \n(37,941 | \n) | \n
| Obligations recognized | \n \u00a0 | \n$ | \n25,275 | \n\u00a0 | \n\u00a0 | \n$ | \n45,547 | \n\u00a0 | \n
Note 5. Intangible Assets
\n\u00a0
\nIntangible assets consisted of the following items:
\n\u00a0
\n \n| \u00a0 | \u00a0 | Customer relationships & distribution channel | \u00a0 | \u00a0 | Licenses, permits & applications | \u00a0 | \u00a0 | Intellectual property, trademarks, knowhow & brands | \u00a0 | \u00a0 | August 31, | \u00a0 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | 2025 | \u00a0 | |
| Cost | \u00a0 | $ | 2,409 | \u00a0 | \u00a0 | $ | 15,047 | \u00a0 | \u00a0 | $ | 16,381 | \u00a0 | \u00a0 | $ | 33,837 | \u00a0 |
| Costs of impaired assets | \u00a0 | \u00a0 | 444,208 | \u00a0 | \u00a0 | \u00a0 | 367,022 | \u00a0 | \u00a0 | \u00a0 | 452,530 | \u00a0 | \u00a0 | \u00a0 | 1,263,760 | \u00a0 |
| Gross carrying amounts | \u00a0 | \u00a0 | 446,617 | \u00a0 | \u00a0 | \u00a0 | 382,069 | \u00a0 | \u00a0 | \u00a0 | 468,911 | \u00a0 | \u00a0 | \u00a0 | 1,297,597 | \u00a0 |
| Accumulated amortization | \u00a0 | \u00a0 | (41 | ) | \u00a0 | \u00a0 | (5,544 | ) | \u00a0 | \u00a0 | (3,079 | ) | \u00a0 | \u00a0 | (8,664 | ) |
| Accumulated impairment losses | \u00a0 | \u00a0 | (444,208 | ) | \u00a0 | \u00a0 | (367,022 | ) | \u00a0 | \u00a0 | (452,530 | ) | \u00a0 | \u00a0 | (1,263,760 | ) |
| Total | \u00a0 | $ | 2,368 | \u00a0 | \u00a0 | $ | 9,503 | \u00a0 | \u00a0 | $ | 13,302 | \u00a0 | \u00a0 | $ | 25,173 | \u00a0 |
\u00a0
\n \n| \u00a0 | \n\u00a0 | \n Customer relationships & distribution channel | \n \u00a0 | \n\u00a0 | \n Licenses, permits & applications | \n \u00a0 | \n\u00a0 | \n Non-compete agreements | \n \u00a0 | \n\u00a0 | \n Intellectual property, trademarks, knowhow & brands | \n \u00a0 | \n\u00a0 | \n May 31, | \n \u00a0 | \n|||||
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n|
| Cost | \n \u00a0 | \n$ | \n610,240 | \n\u00a0 | \n\u00a0 | \n$ | \n387,238 | \n\u00a0 | \n\u00a0 | \n$ | \n12,449 | \n\u00a0 | \n\u00a0 | \n$ | \n618,514 | \n\u00a0 | \n\u00a0 | \n$ | \n1,628,441 | \n\u00a0 | \n
| Accumulated amortization | \n \u00a0 | \n\u00a0 | \n(166,032 | \n) | \n\u00a0 | \n\u00a0 | \n(9,693 | \n) | \n\u00a0 | \n\u00a0 | \n(12,449 | \n) | \n\u00a0 | \n\u00a0 | \n(155,084 | \n) | \n\u00a0 | \n\u00a0 | \n(343,258 | \n) | \n
| Accumulated impairment losses | \n \u00a0 | \n\u00a0 | \n(444,208 | \n) | \n\u00a0 | \n\u00a0 | \n(367,022 | \n) | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(452,530 | \n) | \n\u00a0 | \n\u00a0 | \n(1,263,760 | \n) | \n
| Total | \n \u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n10,523 | \n\u00a0 | \n\u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n10,900 | \n\u00a0 | \n\u00a0 | \n$ | \n21,423 | \n\u00a0 | \n
\u00a0
\nLicenses, permits & applications are predominantly comprised of multi-period\u00a0sponsorship rights.
\n\u00a0
\nExpected future amortization expense for intangible assets as of\u00a0 August 31, 2025\u00a0is\u00a0as follows:
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \n Amortization | \n \u00a0 | \n|
| 2026 (remaining nine months) | \n \u00a0 | \n$ | \n5,737 | \n\u00a0 | \n
| 2027 | \n \u00a0 | \n\u00a0 | \n7,649 | \n\u00a0 | \n
| 2028 | \n \u00a0 | \n\u00a0 | \n4,085 | \n\u00a0 | \n
| 2029 | \n \u00a0 | \n\u00a0 | \n2,897 | \n\u00a0 | \n
| 2030 | \n \u00a0 | \n\u00a0 | \n2,897 | \n\u00a0 | \n
| Thereafter | \n \u00a0 | \n\u00a0 | \n1,908 | \n\u00a0 | \n
| Total | \n \u00a0 | \n$ | \n25,173 | \n\u00a0 | \n
\u00a0
\n \n \n "}]},{"name":"rpt:f-609","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n| \u00a0 | \u00a0 | Customer relationships & distribution channel | \u00a0 | \u00a0 | Licenses, permits & applications | \u00a0 | \u00a0 | Intellectual property, trademarks, knowhow & brands | \u00a0 | \u00a0 | August 31, | \u00a0 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | 2025 | \u00a0 | |
| Cost | \u00a0 | $ | 2,409 | \u00a0 | \u00a0 | $ | 15,047 | \u00a0 | \u00a0 | $ | 16,381 | \u00a0 | \u00a0 | $ | 33,837 | \u00a0 |
| Costs of impaired assets | \u00a0 | \u00a0 | 444,208 | \u00a0 | \u00a0 | \u00a0 | 367,022 | \u00a0 | \u00a0 | \u00a0 | 452,530 | \u00a0 | \u00a0 | \u00a0 | 1,263,760 | \u00a0 |
| Gross carrying amounts | \u00a0 | \u00a0 | 446,617 | \u00a0 | \u00a0 | \u00a0 | 382,069 | \u00a0 | \u00a0 | \u00a0 | 468,911 | \u00a0 | \u00a0 | \u00a0 | 1,297,597 | \u00a0 |
| Accumulated amortization | \u00a0 | \u00a0 | (41 | ) | \u00a0 | \u00a0 | (5,544 | ) | \u00a0 | \u00a0 | (3,079 | ) | \u00a0 | \u00a0 | (8,664 | ) |
| Accumulated impairment losses | \u00a0 | \u00a0 | (444,208 | ) | \u00a0 | \u00a0 | (367,022 | ) | \u00a0 | \u00a0 | (452,530 | ) | \u00a0 | \u00a0 | (1,263,760 | ) |
| Total | \u00a0 | $ | 2,368 | \u00a0 | \u00a0 | $ | 9,503 | \u00a0 | \u00a0 | $ | 13,302 | \u00a0 | \u00a0 | $ | 25,173 | \u00a0 |
| \u00a0 | \n\u00a0 | \n Customer relationships & distribution channel | \n \u00a0 | \n\u00a0 | \n Licenses, permits & applications | \n \u00a0 | \n\u00a0 | \n Non-compete agreements | \n \u00a0 | \n\u00a0 | \n Intellectual property, trademarks, knowhow & brands | \n \u00a0 | \n\u00a0 | \n May 31, | \n \u00a0 | \n|||||
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n|
| Cost | \n \u00a0 | \n$ | \n610,240 | \n\u00a0 | \n\u00a0 | \n$ | \n387,238 | \n\u00a0 | \n\u00a0 | \n$ | \n12,449 | \n\u00a0 | \n\u00a0 | \n$ | \n618,514 | \n\u00a0 | \n\u00a0 | \n$ | \n1,628,441 | \n\u00a0 | \n
| Accumulated amortization | \n \u00a0 | \n\u00a0 | \n(166,032 | \n) | \n\u00a0 | \n\u00a0 | \n(9,693 | \n) | \n\u00a0 | \n\u00a0 | \n(12,449 | \n) | \n\u00a0 | \n\u00a0 | \n(155,084 | \n) | \n\u00a0 | \n\u00a0 | \n(343,258 | \n) | \n
| Accumulated impairment losses | \n \u00a0 | \n\u00a0 | \n(444,208 | \n) | \n\u00a0 | \n\u00a0 | \n(367,022 | \n) | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(452,530 | \n) | \n\u00a0 | \n\u00a0 | \n(1,263,760 | \n) | \n
| Total | \n \u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n10,523 | \n\u00a0 | \n\u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n10,900 | \n\u00a0 | \n\u00a0 | \n$ | \n21,423 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n Amortization | \n \u00a0 | \n|
| 2026 (remaining nine months) | \n \u00a0 | \n$ | \n5,737 | \n\u00a0 | \n
| 2027 | \n \u00a0 | \n\u00a0 | \n7,649 | \n\u00a0 | \n
| 2028 | \n \u00a0 | \n\u00a0 | \n4,085 | \n\u00a0 | \n
| 2029 | \n \u00a0 | \n\u00a0 | \n2,897 | \n\u00a0 | \n
| 2030 | \n \u00a0 | \n\u00a0 | \n2,897 | \n\u00a0 | \n
| Thereafter | \n \u00a0 | \n\u00a0 | \n1,908 | \n\u00a0 | \n
| Total | \n \u00a0 | \n$ | \n25,173 | \n\u00a0 | \n
Note 6. Goodwill
\n\u00a0
\nThe following table shows the carrying amount of goodwill by reporting units:
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n|
| \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n|
| Cannabis Goodwill | \n \u00a0 | \n$ | \n2,640,669 | \n\u00a0 | \n
| Accumulated impairment losses | \n \u00a0 | \n\u00a0 | \n(1,897,431 | \n) | \n
| Effect of foreign exchange | \n \u00a0 | \n\u00a0 | \n9,112 | \n\u00a0 | \n
| Total | \n \u00a0 | \n$ | \n752,350 | \n\u00a0 | \n
\u00a0
\n \n| \u00a0 | \n\u00a0 | \n Reporting Unit | \n \u00a0 | \n\u00a0 | \n May 31, | \n \u00a0 | \n||||||||||||||
| \u00a0 | \n\u00a0 | \n Beverage | \n \u00a0 | \n\u00a0 | \n Cannabis | \n \u00a0 | \n\u00a0 | \n Wellness | \n \u00a0 | \n\u00a0 | \n Distribution | \n \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n|||||
| Goodwill | \n \u00a0 | \n$ | \n120,802 | \n\u00a0 | \n\u00a0 | \n$ | \n2,640,669 | \n\u00a0 | \n\u00a0 | \n$ | \n77,470 | \n\u00a0 | \n\u00a0 | \n$ | \n4,458 | \n\u00a0 | \n\u00a0 | \n$ | \n2,843,399 | \n\u00a0 | \n
| Accumulated impairment losses | \n \u00a0 | \n\u00a0 | \n(120,802 | \n) | \n\u00a0 | \n\u00a0 | \n(1,897,431 | \n) | \n\u00a0 | \n\u00a0 | \n(68,186 | \n) | \n\u00a0 | \n\u00a0 | \n(4,235 | \n) | \n\u00a0 | \n\u00a0 | \n(2,090,654 | \n) | \n
| Effect of foreign exchange | \n \u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n9,112 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(9,284 | \n) | \n\u00a0 | \n\u00a0 | \n(223 | \n) | \n\u00a0 | \n\u00a0 | \n(395 | \n) | \n
| Total | \n \u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n752,350 | \n\u00a0 | \n\u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n752,350 | \n\u00a0 | \n
\u00a0
\n\u00a0
\n \n \n "}]},{"name":"rpt:f-663","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfGoodwillTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n| \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n|
| \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n|
| Cannabis Goodwill | \n \u00a0 | \n$ | \n2,640,669 | \n\u00a0 | \n
| Accumulated impairment losses | \n \u00a0 | \n\u00a0 | \n(1,897,431 | \n) | \n
| Effect of foreign exchange | \n \u00a0 | \n\u00a0 | \n9,112 | \n\u00a0 | \n
| Total | \n \u00a0 | \n$ | \n752,350 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n Reporting Unit | \n \u00a0 | \n\u00a0 | \n May 31, | \n \u00a0 | \n||||||||||||||
| \u00a0 | \n\u00a0 | \n Beverage | \n \u00a0 | \n\u00a0 | \n Cannabis | \n \u00a0 | \n\u00a0 | \n Wellness | \n \u00a0 | \n\u00a0 | \n Distribution | \n \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n|||||
| Goodwill | \n \u00a0 | \n$ | \n120,802 | \n\u00a0 | \n\u00a0 | \n$ | \n2,640,669 | \n\u00a0 | \n\u00a0 | \n$ | \n77,470 | \n\u00a0 | \n\u00a0 | \n$ | \n4,458 | \n\u00a0 | \n\u00a0 | \n$ | \n2,843,399 | \n\u00a0 | \n
| Accumulated impairment losses | \n \u00a0 | \n\u00a0 | \n(120,802 | \n) | \n\u00a0 | \n\u00a0 | \n(1,897,431 | \n) | \n\u00a0 | \n\u00a0 | \n(68,186 | \n) | \n\u00a0 | \n\u00a0 | \n(4,235 | \n) | \n\u00a0 | \n\u00a0 | \n(2,090,654 | \n) | \n
| Effect of foreign exchange | \n \u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n9,112 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(9,284 | \n) | \n\u00a0 | \n\u00a0 | \n(223 | \n) | \n\u00a0 | \n\u00a0 | \n(395 | \n) | \n
| Total | \n \u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n752,350 | \n\u00a0 | \n\u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n752,350 | \n\u00a0 | \n
Note 7.\u00a0Business\u00a0acquisitions
\n\u00a0\u00a0
\nAcquisition of Craft\u00a0Beverage\u00a0Business Portfolio II
\n\u00a0
\nEffective\u00a0\u00a0 September 1, 2024,\u00a0the Company acquired\u00a0\u00a0craft beer brands and breweries from Molson Coors Beverage Company\u00a0(\u201cMolson\u201d) including Atwater Brewery,\u00a0Hop Valley Brewing Company,\u00a0Terrapin Beer Co., and\u00a0Revolver Brewing (the \u201cCraft\u00a0Acquisition II\u201d).\u00a0The purpose of the acquisition was to continue broadening Tilray's beverage brand strategy. In consideration for the acquisition, the Company paid a total purchase price\u00a0of $22,979\u00a0in cash, which was\u00a0subject to certain customary post-closing working capital adjustments.
\n\u00a0
\nThe table below summarizes the fair value of the assets acquired and the liabilities assumed for the Craft Acquisition II\u00a0at the effective acquisition date\u00a0as follows:\u00a0
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \n Amount | \n \u00a0 | \n|
| Consideration | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Cash consideration | \n \u00a0 | \n$ | \n22,979 | \n\u00a0 | \n
| Net assets acquired | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Current assets | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Cash and cash equivalents | \n \u00a0 | \n\u00a0 | \n4,869 | \n\u00a0 | \n
| Accounts receivable | \n \u00a0 | \n\u00a0 | \n1,993 | \n\u00a0 | \n
| Inventory | \n \u00a0 | \n\u00a0 | \n6,844 | \n\u00a0 | \n
| Prepaids and other current assets | \n \u00a0 | \n\u00a0 | \n185 | \n\u00a0 | \n
| Long-term assets | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Capital assets | \n \u00a0 | \n\u00a0 | \n20,916 | \n\u00a0 | \n
| Finance lease, right-of-use assets | \n \u00a0 | \n\u00a0 | \n1,869 | \n\u00a0 | \n
| Operating lease, right-of-use assets | \n \u00a0 | \n\u00a0 | \n1,884 | \n\u00a0 | \n
| Total assets | \n \u00a0 | \n\u00a0 | \n38,560 | \n\u00a0 | \n
| Current liabilities | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Accounts payable and accrued liabilities | \n \u00a0 | \n\u00a0 | \n11,828 | \n\u00a0 | \n
| Current portion of finance lease liabilities | \n \u00a0 | \n\u00a0 | \n354 | \n\u00a0 | \n
| Current portion of operating lease liabilities | \n \u00a0 | \n\u00a0 | \n564 | \n\u00a0 | \n
| Long - term liabilities | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Finance lease liabilities | \n \u00a0 | \n\u00a0 | \n1,515 | \n\u00a0 | \n
| Operating lease liabilities | \n \u00a0 | \n\u00a0 | \n1,320 | \n\u00a0 | \n
| Total liabilities | \n \u00a0 | \n\u00a0 | \n15,581 | \n\u00a0 | \n
| Total net assets acquired | \n \u00a0 | \n\u00a0 | \n22,979 | \n\u00a0 | \n
\u00a0
\nIn the event that the Craft Acquisition II had occurred on June 1, 2024, the Company would have had, on an unaudited proforma basis, additional net\u00a0revenue of approximately \u00a0for the three months ended August 31, 2025 and\u00a0approximately $13,700 for the\u00a0three months ended August 31, 2024, respectively, and its consolidated net income and comprehensive net income\u00a0would have increased by approximately\u00a0\u00a0for the three months ended August 31, 2025 and approximately $4,000 for the\u00a0three months ended August 31, 2024, respectively. This unaudited pro forma financial information does\u00a0not\u00a0reflect the realization of any expected ongoing synergies relating to the integration of the Craft Acquisition II.
\n\u00a0
\n "}]},{"name":"rpt:f-689","factDimensions":{"xbrl:concept":"us-gaap:PaymentsToAcquireBusinessesGross","xbrl:period":"2024-09-01T00:00:00/2024-09-02T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"tlry:CraftBeverageBusinessAcquisitionIIMember"},"factValues":[{"value":"22979000","decimals":-3}]},{"name":"rpt:f-690","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n| \u00a0 | \n\u00a0 | \n Amount | \n \u00a0 | \n|
| Consideration | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Cash consideration | \n \u00a0 | \n$ | \n22,979 | \n\u00a0 | \n
| Net assets acquired | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Current assets | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Cash and cash equivalents | \n \u00a0 | \n\u00a0 | \n4,869 | \n\u00a0 | \n
| Accounts receivable | \n \u00a0 | \n\u00a0 | \n1,993 | \n\u00a0 | \n
| Inventory | \n \u00a0 | \n\u00a0 | \n6,844 | \n\u00a0 | \n
| Prepaids and other current assets | \n \u00a0 | \n\u00a0 | \n185 | \n\u00a0 | \n
| Long-term assets | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Capital assets | \n \u00a0 | \n\u00a0 | \n20,916 | \n\u00a0 | \n
| Finance lease, right-of-use assets | \n \u00a0 | \n\u00a0 | \n1,869 | \n\u00a0 | \n
| Operating lease, right-of-use assets | \n \u00a0 | \n\u00a0 | \n1,884 | \n\u00a0 | \n
| Total assets | \n \u00a0 | \n\u00a0 | \n38,560 | \n\u00a0 | \n
| Current liabilities | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Accounts payable and accrued liabilities | \n \u00a0 | \n\u00a0 | \n11,828 | \n\u00a0 | \n
| Current portion of finance lease liabilities | \n \u00a0 | \n\u00a0 | \n354 | \n\u00a0 | \n
| Current portion of operating lease liabilities | \n \u00a0 | \n\u00a0 | \n564 | \n\u00a0 | \n
| Long - term liabilities | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Finance lease liabilities | \n \u00a0 | \n\u00a0 | \n1,515 | \n\u00a0 | \n
| Operating lease liabilities | \n \u00a0 | \n\u00a0 | \n1,320 | \n\u00a0 | \n
| Total liabilities | \n \u00a0 | \n\u00a0 | \n15,581 | \n\u00a0 | \n
| Total net assets acquired | \n \u00a0 | \n\u00a0 | \n22,979 | \n\u00a0 | \n
Note 8. Long term investments
\n\u00a0
\nLong term investments consisted of the following:
\n\u00a0
\n \n| \u00a0 | \u00a0 | August 31, | \u00a0 | \u00a0 | May 31, | \u00a0 | ||
| \u00a0 | \u00a0 | 2025 | \u00a0 | \u00a0 | 2025 | \u00a0 | ||
| Equity investments measured at fair value | \u00a0 | $ | 2,012 | \u00a0 | \u00a0 | $ | 1,972 | \u00a0 |
| Equity investments under measurement alternative | \u00a0 | \u00a0 | 8,160 | \u00a0 | \u00a0 | \u00a0 | 8,160 | \u00a0 |
| Total | \u00a0 | $ | 10,172 | \u00a0 | \u00a0 | $ | 10,132 | \u00a0 |
\u00a0
\nAs of August 31, 2025\u00a0and May 31, 2025, included within equity investment under measurement alternative is an option to acquire a\u00a068% membership interest in\u00a0SH Acquisition\u00a0for $1.00 upon U.S. federal cannabis legalization valued at $8,160.\u00a0See Note 24\u00a0(Financial risk management and financial instruments).\u00a0
\n\u00a0
\n \n \n "}]},{"name":"rpt:f-710","factDimensions":{"xbrl:concept":"us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n| \u00a0 | \u00a0 | August 31, | \u00a0 | \u00a0 | May 31, | \u00a0 | ||
| \u00a0 | \u00a0 | 2025 | \u00a0 | \u00a0 | 2025 | \u00a0 | ||
| Equity investments measured at fair value | \u00a0 | $ | 2,012 | \u00a0 | \u00a0 | $ | 1,972 | \u00a0 |
| Equity investments under measurement alternative | \u00a0 | \u00a0 | 8,160 | \u00a0 | \u00a0 | \u00a0 | 8,160 | \u00a0 |
| Total | \u00a0 | $ | 10,172 | \u00a0 | \u00a0 | $ | 10,132 | \u00a0 |
Note 9. Bank indebtedness
\n\u00a0
\nAphria Inc., a subsidiary of the Company,\u00a0has an operating line of credit in the amount of which bears interest at the lender\u2019s prime rate plus 75 basis points. As of August 31, 2025, the Company has drawn on the line of credit. The operating line of credit is secured by a security interest on certain real property located\u00a0at 265 Talbot St. West, Leamington, Ontario.
\n\u00a0
\nCC Pharma GmbH, a subsidiary of the Company, has \u00a0operating lines of credit in the amounts of\u00a0\u00a0and\u00a0\u00a0These lines\u00a0bear interest at\u00a0Euro Short-Term Rate (\u201cESTR\u201d) plus 2.50% and Euro Interbank Offered Rate (\u201cEURIBOR\u201d) plus 4.00%, respectively. As of August 31, 2025, a total of ($8,185) was drawn down from the total available credit of\u00a0\u00a0The operating line\u00a0of credit for \u00a0is secured by an interest in the inventory of CC Pharma GmbH as well as\u00a0the Densborn, Germany production facility and underlying real property. The operating line of credit for is unsecured.
\n\u00a0
\nOn\u00a0 July 25, 2025,\u00a0the Company\u2019s wholly-owned subsidiary, American Beverage Crafts Group Inc. (\u201cABC Group\u201d), formerly known as\u00a0Four Twenty Corporation, finalized its\u00a0fifth\u00a0amendment (the \u201cAmendment\u201d) to that certain Credit Agreement dated as of\u00a0 June 30, 2023 (the \u201cABC Group Credit Agreement\u201d) by and among the Borrower, Bank of America, N.A., in its capacity as Administrative Agent, and certain other guarantors and lenders party thereto. Specifically, the Amendment amended and restated the ABC Group Credit Agreement to provide for the contribution of the Manitoba Harvest entities\u2019 equity to the Borrower as additional collateral.\u00a0 Additionally, the Amendment added financial covenants for (i) minimum consolidated trailing-twelve-months EBITDA for each of the\u00a0four\u00a0quarters, beginning\u00a0 May 31, 2025\u00a0and (ii) minimum liquidity.\u00a0ABC Group has a revolving credit facility of $25,000, which bears interest at SOFR plus an applicable margin. As of\u00a0\u00a0 August 31, 2025, the Company has drawn\u00a0\u00a0on the revolving line of credit.\u00a0
\n\u00a0
\n "}]},{"name":"rpt:f-721","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentBasisSpreadOnVariableRate1","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","us-gaap:ShortTermDebtTypeAxis":"us-gaap:LineOfCreditMember","us-gaap:VariableRateAxis":"us-gaap:PrimeRateMember"},"factValues":[{"value":"0.75","decimals":2}]},{"name":"rpt:f-722","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentBasisSpreadOnVariableRate1","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","srt:ConsolidatedEntitiesAxis":"tlry:CCPharmaGmbHMember","us-gaap:ShortTermDebtTypeAxis":"us-gaap:LineOfCreditMember","us-gaap:VariableRateAxis":"tlry:EuroShorttermRateMember"},"factValues":[{"value":"0.025","decimals":3}]},{"name":"rpt:f-723","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentBasisSpreadOnVariableRate1","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","srt:ConsolidatedEntitiesAxis":"tlry:CCPharmaGmbHMember","us-gaap:ShortTermDebtTypeAxis":"us-gaap:LineOfCreditMember","us-gaap:VariableRateAxis":"tlry:EuroInterbankOfferedRateMember"},"factValues":[{"value":"0.04","decimals":2}]},{"name":"rpt:f-724","factDimensions":{"xbrl:concept":"us-gaap:LineOfCredit","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","srt:ConsolidatedEntitiesAxis":"tlry:CCPharmaGmbHMember","us-gaap:ShortTermDebtTypeAxis":"us-gaap:LineOfCreditMember"},"factValues":[{"value":"8185000","decimals":-3}]},{"name":"rpt:f-725","factDimensions":{"xbrl:concept":"us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity","xbrl:period":"2025-07-26T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","srt:ConsolidatedEntitiesAxis":"tlry:AmericanBeverageCraftsGroupIncMember","us-gaap:CreditFacilityAxis":"us-gaap:RevolvingCreditFacilityMember"},"factValues":[{"value":"25000000","decimals":-6}]},{"name":"rpt:f-726","factDimensions":{"xbrl:concept":"us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \nNote 10. Accounts payable and accrued liabilities
\n\u00a0
\nAccounts payable and accrued liabilities are comprised of:
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \nAugust 31, | \n\u00a0 | \n\u00a0 | \nMay 31, | \n\u00a0 | \n||
| \u00a0 | \n\u00a0 | \n2025 | \n\u00a0 | \n\u00a0 | \n2025 | \n\u00a0 | \n||
| Trade payables | \n \u00a0 | \n$ | \n110,802 | \n\u00a0 | \n\u00a0 | \n$ | \n107,348 | \n\u00a0 | \n
| Accrued liabilities | \n \u00a0 | \n\u00a0 | \n91,993 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n103,260 | \n\u00a0 | \n
| Litigation accruals | \n \u00a0 | \n\u00a0 | \n12,021 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n12,431 | \n\u00a0 | \n
| Accrued payroll and employment related taxes | \n \u00a0 | \n\u00a0 | \n2,796 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n1,436 | \n\u00a0 | \n
| Income taxes payable | \n \u00a0 | \n\u00a0 | \n1,038 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n58 | \n\u00a0 | \n
| Accrued interest | \n \u00a0 | \n\u00a0 | \n2,677 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n4,193 | \n\u00a0 | \n
| Sales taxes payable | \n \u00a0 | \n\u00a0 | \n9,586 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n6,596 | \n\u00a0 | \n
| Total | \n \u00a0 | \n$ | \n230,913 | \n\u00a0 | \n\u00a0 | \n$ | \n235,322 | \n\u00a0 | \n
\u00a0 \u00a0 \u00a0
\n \n \n "}]},{"name":"rpt:f-727","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n| \u00a0 | \n\u00a0 | \nAugust 31, | \n\u00a0 | \n\u00a0 | \nMay 31, | \n\u00a0 | \n||
| \u00a0 | \n\u00a0 | \n2025 | \n\u00a0 | \n\u00a0 | \n2025 | \n\u00a0 | \n||
| Trade payables | \n \u00a0 | \n$ | \n110,802 | \n\u00a0 | \n\u00a0 | \n$ | \n107,348 | \n\u00a0 | \n
| Accrued liabilities | \n \u00a0 | \n\u00a0 | \n91,993 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n103,260 | \n\u00a0 | \n
| Litigation accruals | \n \u00a0 | \n\u00a0 | \n12,021 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n12,431 | \n\u00a0 | \n
| Accrued payroll and employment related taxes | \n \u00a0 | \n\u00a0 | \n2,796 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n1,436 | \n\u00a0 | \n
| Income taxes payable | \n \u00a0 | \n\u00a0 | \n1,038 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n58 | \n\u00a0 | \n
| Accrued interest | \n \u00a0 | \n\u00a0 | \n2,677 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n4,193 | \n\u00a0 | \n
| Sales taxes payable | \n \u00a0 | \n\u00a0 | \n9,586 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n6,596 | \n\u00a0 | \n
| Total | \n \u00a0 | \n$ | \n230,913 | \n\u00a0 | \n\u00a0 | \n$ | \n235,322 | \n\u00a0 | \n
Note 11. Long-term debt
\n\u00a0
\nThe following table sets forth the net carrying amount of long-term debt instruments:
\n\u00a0
\n \n| \u00a0 | \u00a0 | August 31, | \u00a0 | \u00a0 | May 31, | \u00a0 | ||
| \u00a0 | \u00a0 | 2025 | \u00a0 | \u00a0 | 2025 | \u00a0 | ||
| Term loan - C$ - Canadian prime plus an applicable margin, -year term, with a -year amortization, repayable in equal quarterly payments due in | \u00a0 | $ | 38,690 | \u00a0 | \u00a0 | $ | 38,690 | \u00a0 |
| Term loan - C$ - Canadian prime plus %, compounded monthly, -year term, with a -year amortization, repayable in equal monthly installments of C$ including interest, due in | \u00a0 | \u00a0 | 11,222 | \u00a0 | \u00a0 | \u00a0 | 11,501 | \u00a0 |
| Term loan - C$ - Canadian prime plus %, compounded monthly, -year term, with a -year amortization, repayable in equal monthly installments of C$ including interest, due in | \u00a0 | \u00a0 | 9,127 | \u00a0 | \u00a0 | \u00a0 | 9,354 | \u00a0 |
| Term loan - C$ - Canadian prime plus %, -year term, with a -year amortization, repayable in equal monthly installments of C$ including interest, due in | \u00a0 | \u00a0 | 125 | \u00a0 | \u00a0 | \u00a0 | 157 | \u00a0 |
| Mortgage payable - C$ - Canadian prime plus %, -year term, with a -year amortization, repayable in equal monthly installments of C$ including interest, due in | \u00a0 | \u00a0 | 1,988 | \u00a0 | \u00a0 | \u00a0 | 2,020 | \u00a0 |
| Term loan \u2010 \u20ac \u2010 at %, \u2010year term, repayable in monthly installments of \u20ac plus interest, due in | \u00a0 | \u00a0 | 2,437 | \u00a0 | \u00a0 | \u00a0 | 2,546 | \u00a0 |
| Mortgage payable - $ - EURIBOR rate plus %, -year term, repayable in monthly installments of $ to $, due in | \u00a0 | \u00a0 | 19,233 | \u00a0 | \u00a0 | \u00a0 | 19,418 | \u00a0 |
| Term loan - $ - SOFR plus an applicable margin, -year term, repayable in quarterly installments of $ to $ due in | \u00a0 | \u00a0 | 78,750 | \u00a0 | \u00a0 | \u00a0 | 80,438 | \u00a0 |
| Carrying amount of long-term debt | \u00a0 | \u00a0 | 161,572 | \u00a0 | \u00a0 | \u00a0 | 164,124 | \u00a0 |
| Unamortized financing fees | \u00a0 | \u00a0 | (1,102 | ) | \u00a0 | \u00a0 | (864 | ) |
| Net carrying amount | \u00a0 | \u00a0 | 160,470 | \u00a0 | \u00a0 | \u00a0 | 163,260 | \u00a0 |
| Less principal portion included in current liabilities | \u00a0 | \u00a0 | (16,295 | ) | \u00a0 | \u00a0 | (14,767 | ) |
| Total non-current portion of long-term debt | \u00a0 | $ | 144,175 | \u00a0 | \u00a0 | $ | 148,493 | \u00a0 |
\u00a0
\n \n \n "}]},{"name":"rpt:f-745","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfDebtInstrumentsTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n| \u00a0 | \u00a0 | August 31, | \u00a0 | \u00a0 | May 31, | \u00a0 | ||
| \u00a0 | \u00a0 | 2025 | \u00a0 | \u00a0 | 2025 | \u00a0 | ||
| Term loan - C$ - Canadian prime plus an applicable margin, -year term, with a -year amortization, repayable in equal quarterly payments due in | \u00a0 | $ | 38,690 | \u00a0 | \u00a0 | $ | 38,690 | \u00a0 |
| Term loan - C$ - Canadian prime plus %, compounded monthly, -year term, with a -year amortization, repayable in equal monthly installments of C$ including interest, due in | \u00a0 | \u00a0 | 11,222 | \u00a0 | \u00a0 | \u00a0 | 11,501 | \u00a0 |
| Term loan - C$ - Canadian prime plus %, compounded monthly, -year term, with a -year amortization, repayable in equal monthly installments of C$ including interest, due in | \u00a0 | \u00a0 | 9,127 | \u00a0 | \u00a0 | \u00a0 | 9,354 | \u00a0 |
| Term loan - C$ - Canadian prime plus %, -year term, with a -year amortization, repayable in equal monthly installments of C$ including interest, due in | \u00a0 | \u00a0 | 125 | \u00a0 | \u00a0 | \u00a0 | 157 | \u00a0 |
| Mortgage payable - C$ - Canadian prime plus %, -year term, with a -year amortization, repayable in equal monthly installments of C$ including interest, due in | \u00a0 | \u00a0 | 1,988 | \u00a0 | \u00a0 | \u00a0 | 2,020 | \u00a0 |
| Term loan \u2010 \u20ac \u2010 at %, \u2010year term, repayable in monthly installments of \u20ac plus interest, due in | \u00a0 | \u00a0 | 2,437 | \u00a0 | \u00a0 | \u00a0 | 2,546 | \u00a0 |
| Mortgage payable - $ - EURIBOR rate plus %, -year term, repayable in monthly installments of $ to $, due in | \u00a0 | \u00a0 | 19,233 | \u00a0 | \u00a0 | \u00a0 | 19,418 | \u00a0 |
| Term loan - $ - SOFR plus an applicable margin, -year term, repayable in quarterly installments of $ to $ due in | \u00a0 | \u00a0 | 78,750 | \u00a0 | \u00a0 | \u00a0 | 80,438 | \u00a0 |
| Carrying amount of long-term debt | \u00a0 | \u00a0 | 161,572 | \u00a0 | \u00a0 | \u00a0 | 164,124 | \u00a0 |
| Unamortized financing fees | \u00a0 | \u00a0 | (1,102 | ) | \u00a0 | \u00a0 | (864 | ) |
| Net carrying amount | \u00a0 | \u00a0 | 160,470 | \u00a0 | \u00a0 | \u00a0 | 163,260 | \u00a0 |
| Less principal portion included in current liabilities | \u00a0 | \u00a0 | (16,295 | ) | \u00a0 | \u00a0 | (14,767 | ) |
| Total non-current portion of long-term debt | \u00a0 | $ | 144,175 | \u00a0 | \u00a0 | $ | 148,493 | \u00a0 |
Note 12. Convertible debentures payable
\n\u00a0
\nThe following table sets forth the net carrying amount of the convertible debentures payable:
\n\u00a0
\n \n| \u00a0 | \u00a0 | August 31, | \u00a0 | \u00a0 | May 31, | \u00a0 | ||
| \u00a0 | \u00a0 | 2025 | \u00a0 | \u00a0 | 2025 | \u00a0 | ||
| % Convertible Notes (\"TLRY 27\") | \u00a0 | $ | 84,267 | \u00a0 | \u00a0 | $ | 86,428 | \u00a0 |
| Deduct - current portion | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 |
| Total convertible debentures payable, non current portion | \u00a0 | $ | 84,267 | \u00a0 | \u00a0 | $ | 86,428 | \u00a0 |
\u00a0
\nTLRY 27 Notes
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n\u00a0 | \n May 31, | \n \u00a0 | \n||
| \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n||
| 5.20% Contractual debenture | \n \u00a0 | \n$ | \n172,500 | \n\u00a0 | \n\u00a0 | \n$ | \n172,500 | \n\u00a0 | \n
| Debt settlement | \n \u00a0 | \n\u00a0 | \n(72,500 | \n) | \n\u00a0 | \n\u00a0 | \n(67,500 | \n) | \n
| Unamortized discount | \n \u00a0 | \n\u00a0 | \n(15,733 | \n) | \n\u00a0 | \n\u00a0 | \n(18,572 | \n) | \n
| Net carrying amount | \n \u00a0 | \n$ | \n84,267 | \n\u00a0 | \n\u00a0 | \n$ | \n86,428 | \n\u00a0 | \n
\u00a0
\nThe TLRY\u00a027\u00a0convertible debentures\u00a0were issued\u00a0on\u00a0 May 30, 2023 and on June 9, 2023 by way of overallotment,\u00a0in the principal amount of $172,500 (the \u201cTLRY 27 Notes\u201d). The TLRY 27 Notes\u00a0bear interest at a rate of\u00a05.20% per annum, payable semi-annually in arrears on\u00a0 June 15\u00a0and\u00a0 December 15\u00a0of each year, and mature on\u00a0 June 15, 2027,\u00a0unless earlier converted. The TLRY 27 Notes are Tilray\u2019s general unsecured obligations and rank senior in right of payment to all of Tilray\u2019s indebtedness that is expressly subordinated in right of payment to the notes; equal in right of payment with any of Tilray\u2019s unsecured indebtedness that is not so subordinated,\u00a0effectively junior in right of payment to any of Tilray\u2019s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables but excluding intercompany obligations) of Tilray\u2019s current or future subsidiaries.\u00a0Noteholders have the right to convert their TLRY\u00a027\u00a0Notes into shares of Tilray\u2019s Common Stock at their option, at any time, until the close of business on the\u00a0second\u00a0scheduled trading day immediately before\u00a0 June 15, 2027.\u00a0The initial conversion rate is\u00a0376.6478\u00a0shares per\u00a0$1,000\u00a0principal amount of TLRY\u00a027\u00a0Notes, which represents a conversion price of approximately\u00a0$2.66\u00a0per share. The conversion rate and conversion price will be subject to adjustment upon the occurrence of certain events.
\n\u00a0
\nThe TLRY\u00a027\u00a0Notes are now\u00a0redeemable, in whole and\u00a0not\u00a0in part, at Tilray\u2019s option at any time on or after\u00a0\u00a0 June 20, 2025\u00a0at a cash redemption price equal to the principal amount of the notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date, but only if the last reported sale price of Tilray\u2019s Common Stock exceeds\u00a0130% of the conversion price for a specified period of time. If certain corporate events that constitute a fundamental change occur, then, subject to a limited exception, noteholders\u00a0 may\u00a0require\u00a0Tilray\u00a0to repurchase their TLRY\u00a027\u00a0Notes for cash. The repurchase price will be equal to the principal amount of the notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the applicable repurchase date. In connection with the Company\u2019s offering of the TLRY\u00a027\u00a0Notes, the Company entered into a share lending agreement with an affiliate of\u00a0Jefferies LLC\u00a0(the \u201cShare Borrower\u201d), pursuant to which it lent\u00a0to the Share Borrower\u00a038,500,000\u00a0shares of the Company\u2019s Common Stock (the \u201cBorrowed Shares\u201d). The Borrowed Shares were newly-issued shares,\u00a0will be held as treasury shares until the expiration or early termination of the share lending agreement\u00a0and may be used by purchasers of the TLRY\u00a027\u00a0Notes\u00a0to sell up to\u00a038,500,000\u00a0shares of the Company\u2019s Common Stock. The fair value of the share lending agreement has been recorded as part of the unamortized discount on the debenture. The Company expects that the selling stockholders will use their position created by such sales to establish their initial hedge with respect to their investments in the TLRY\u00a027\u00a0Notes. The Company did\u00a0not\u00a0receive any proceeds from the sale of the Borrowed Shares.\u00a0
\n\u00a0
\nDuring the three months ended August 31, 2025,\u00a0the Company exchanged an aggregate $5,000 of its TLRY\u00a027\u00a0Notes for cancellation, by issuing\u00a012,591,816 shares of Common Stock and paying $6 in cash to settle\u00a0accrued interest. Upon exchanging\u00a0the TLRY\u00a027\u00a0Notes, a portion of the\u00a0settlement consideration was allocated to the equity component of the instrument and\u00a0was\u00a0recognized as a $1,158 reduction of additional paid-in capital in the Consolidated Statements of Stockholders\u2019 Equity. Additionally, this repurchase resulted in a gain\u00a0of $495 which was recorded in other non-operating (losses) gains, net as shown in Note\u00a023\u00a0(Non-operating income (expense)).\u00a0Following consummation of the exchange, the number of outstanding Borrowed Shares of Common Stock was reduced by 1,209,696 shares which were then returned\u00a0as Treasury Stock.\u00a0As of\u00a0 August 31, 2025\u00a0and May 31, 2025, a total of 22,318,841 and\u00a023,434,783 shares remained outstanding under the\u00a0share lending\u00a0arrangement, respectively.\u00a0
\n\u00a0
\nDuring the three months ended August 31, 2025, the Company recognized interest expense\u00a0of $1,367 and accretion of amortized discount interest of $1,976. During the three months ended August 31,\u00a02024, the Company recognized interest expense of $2,243 and accretion of amortized discount interest of $3,067.\u00a0
\n\u00a0
\nAs of\u00a0 August 31, 2025, there was $100,000 principal outstanding compared to $105,000 principal outstanding as of\u00a0 May 31, 2025 under the TLRY 27 Notes.
\n\u00a0
\n \n \n "}]},{"name":"rpt:f-773","factDimensions":{"xbrl:concept":"us-gaap:ConvertibleDebtTableTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n| \u00a0 | \u00a0 | August 31, | \u00a0 | \u00a0 | May 31, | \u00a0 | ||
| \u00a0 | \u00a0 | 2025 | \u00a0 | \u00a0 | 2025 | \u00a0 | ||
| % Convertible Notes (\"TLRY 27\") | \u00a0 | $ | 84,267 | \u00a0 | \u00a0 | $ | 86,428 | \u00a0 |
| Deduct - current portion | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 |
| Total convertible debentures payable, non current portion | \u00a0 | $ | 84,267 | \u00a0 | \u00a0 | $ | 86,428 | \u00a0 |
| \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n\u00a0 | \n May 31, | \n \u00a0 | \n||
| \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n||
| 5.20% Contractual debenture | \n \u00a0 | \n$ | \n172,500 | \n\u00a0 | \n\u00a0 | \n$ | \n172,500 | \n\u00a0 | \n
| Debt settlement | \n \u00a0 | \n\u00a0 | \n(72,500 | \n) | \n\u00a0 | \n\u00a0 | \n(67,500 | \n) | \n
| Unamortized discount | \n \u00a0 | \n\u00a0 | \n(15,733 | \n) | \n\u00a0 | \n\u00a0 | \n(18,572 | \n) | \n
| Net carrying amount | \n \u00a0 | \n$ | \n84,267 | \n\u00a0 | \n\u00a0 | \n$ | \n86,428 | \n\u00a0 | \n
Note 13. Warrant liability
\n\u00a0
\nAs of August 31, 2025 and May 31, 2025, there were 6,209,000 warrants outstanding, with an original exercise price of $5.95 per warrant, expiring September 17, 2025.\u00a0Each warrant is exercisable for share of Common Stock of the Company.
\n\u00a0
\nThe warrants contain anti-dilution price protection features, which adjust the exercise price of the warrants if the Company subsequently issues Common Stock at a price lower than the exercise price of the warrants. In the event additional warrants or convertible debt are issued with a lower and/or variable exercise price, the exercise price of the warrants will be adjusted accordingly. During the three\u00a0months ended August 31, 2025, the Company issued shares of its Common Stock which triggered the anti-dilution price protection feature and, accordingly, lowered\u00a0the exercise price of each warrant to $0.38. These warrants are classified as liabilities as they are to be settled in registered shares, and the registration statement is required to be active, unless such shares may be subject to an applicable exemption from registration requirements. The holders, at their sole discretion, may elect to affect a cashless exercise, and be issued exempt securities in accordance with Section 3(a)(9) of the Securities Act of 1933, as amended. In the event the Company does not maintain an effective registration statement, the Company may be required to pay a daily cash penalty equal to 1% of the number of shares of Common Stock due to be issued multiplied by any trading price of the Common Stock between the exercise date and the share delivery date, as selected by the holder. Alternatively, the Company may deliver registered Common Stock purchased by the Company in the open market. The Company may also be required to pay cash if it does not have sufficient authorized shares to deliver to the holders upon exercise.
\n\u00a0
\nUsing the Black Scholes pricing model (Level 3), the Company has estimated the fair value of the warrants outstanding as of\u00a0 August 31, 2025\u00a0to be\u00a0$1.00 per warrant.\u00a0In applying the Black Scholes pricing model (Level 3), the Company utilized the following assumptions: a risk-free interest rate of 2.64%, an expected volatility of 50%, an expected term of 0.05 years, strike price of $0.38\u00a0and fair value of Common Stock of $1.38.\u00a0\u00a0See Note 26\u00a0(Subsequent events) as all\u00a0outstanding warrants were exercised after the period.
\n\u00a0
\nExpected volatility is based on both historical and implied volatility of the Company\u2019s common stock.
\n\u00a0
\n "}]},{"name":"rpt:f-811","factDimensions":{"xbrl:concept":"us-gaap:ClassOfWarrantOrRightOutstanding","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"6209000"}]},{"name":"rpt:f-812","factDimensions":{"xbrl:concept":"us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD/xbrla:shares"},"factValues":[{"value":"5.95"}]},{"name":"rpt:f-813","factDimensions":{"xbrl:concept":"us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD/xbrla:shares","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"0.38"}]},{"name":"rpt:f-814","factDimensions":{"xbrl:concept":"tlry:PercentageOfDailyCashPenalty","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":"0.01","decimals":2}]},{"name":"rpt:f-815","factDimensions":{"xbrl:concept":"tlry:EstimatedFairValueOfWarrantLiabilityPerWarrant","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:FairValueByFairValueHierarchyLevelAxis":"us-gaap:FairValueInputsLevel3Member"},"factValues":[{"value":"1"}]},{"name":"rpt:f-816","factDimensions":{"xbrl:concept":"us-gaap:WarrantsAndRightsOutstandingMeasurementInput","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","us-gaap:FairValueByFairValueHierarchyLevelAxis":"us-gaap:FairValueInputsLevel3Member","us-gaap:MeasurementInputTypeAxis":"us-gaap:MeasurementInputRiskFreeInterestRateMember"},"factValues":[{"value":"0.0264","decimals":4}]},{"name":"rpt:f-817","factDimensions":{"xbrl:concept":"us-gaap:WarrantsAndRightsOutstandingMeasurementInput","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","us-gaap:FairValueByFairValueHierarchyLevelAxis":"us-gaap:FairValueInputsLevel3Member","us-gaap:MeasurementInputTypeAxis":"us-gaap:MeasurementInputPriceVolatilityMember"},"factValues":[{"value":"0.50","decimals":1}]},{"name":"rpt:f-818","factDimensions":{"xbrl:concept":"us-gaap:WarrantsAndRightsOutstandingMeasurementInput","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","us-gaap:FairValueByFairValueHierarchyLevelAxis":"us-gaap:FairValueInputsLevel3Member","us-gaap:MeasurementInputTypeAxis":"us-gaap:MeasurementInputExpectedTermMember"},"factValues":[{"value":"0.05"}]},{"name":"rpt:f-819","factDimensions":{"xbrl:concept":"us-gaap:WarrantsAndRightsOutstandingMeasurementInput","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","us-gaap:FairValueByFairValueHierarchyLevelAxis":"us-gaap:FairValueInputsLevel3Member","us-gaap:MeasurementInputTypeAxis":"us-gaap:MeasurementInputConversionPriceMember"},"factValues":[{"value":"0.38"}]},{"name":"rpt:f-820","factDimensions":{"xbrl:concept":"us-gaap:WarrantsAndRightsOutstandingMeasurementInput","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","us-gaap:FairValueByFairValueHierarchyLevelAxis":"us-gaap:FairValueInputsLevel3Member","us-gaap:MeasurementInputTypeAxis":"us-gaap:MeasurementInputSharePriceMember"},"factValues":[{"value":"1.38"}]},{"name":"rpt:f-821","factDimensions":{"xbrl:concept":"us-gaap:StockholdersEquityNoteDisclosureTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \nNote 14. Stockholders' equity\u00a0
\n\u00a0
\nIssued and outstanding
\n\u00a0
\nPursuant to its Fifth Amended and Restated Certificate of Incorporation, the total number of shares that the Company is authorized to issue is 1,426,000,000 shares, of which 1,416,000,000 shares are Common Stock (the \u201cCommon Stock\u201d), and 10,000,000\u00a0shares of which are Preferred Stock (the \u201cPreferred Stock\u201d). As of\u00a0 August 31, 2025, the Company had issued and outstanding 1,118,291,159 shares of Common Stock, 3,213,914 shares of Treasury Stock\u00a0(the \u201cTreasury\u00a0Stock\u201d)\u00a0and no\u00a0Preferred Stock. Historically, the Company has issued shares of its Common Stock in\u00a0consideration for acquisitions and other\u00a0strategic transactions, settlement of convertible notes,\u00a0settlement of litigation claims, in connection with public offerings and as payment of dividends to non-controlling interests for profit distributions.
\n\u00a0
\nDuring the three months ended August 31, 2025, the Company issued the following shares of Common Stock:
\n\u00a0
\n| \u00a0 | a) | 34,443,799\u00a0shares of Common Stock pursuant to\u00a0its At-the-Market (\u201cATM\u201d) program, which generated gross proceeds\u00a0of $23,044 and net proceeds of $22,491, after deducting\u00a0$553\u00a0in commissions and other fees associated with these issuances. |
| \u00a0 | b) | 12,591,816\u00a0shares of Common Stock in the amount of $4,800\u00a0to exchange\u00a0the\u00a0aggregate\u00a0principal of $5,000 of its TLRY 27\u00a0Notes for cancellation.\u00a0Upon exchanging\u00a0the TLRY\u00a027\u00a0Notes, a portion of the\u00a0settlement consideration was allocated to the equity component of the instrument and\u00a0was\u00a0recognized as a $1,158\u00a0reduction of additional paid-in capital. Following consummation of the exchange, the number of outstanding Borrowed Shares of Common Stock was reduced by approximately 1,209,696\u00a0shares which were then returned\u00a0as Treasury Stock, see Note 12\u00a0(Convertible debentures payable). |
| \u00a0 | c) | 10,576,799\u00a0shares of Common Stock in connection with the exercise of previously awarded stock-based compensation awards. |
\u00a0
\nDuring the three months ended August 31, 2025, the Company granted 44,802,378 time-based Restricted Stock Units (\u201cRSUs\u201d),\u00a0and performance-based RSUs.
\n\u00a0
\nDuring the fiscal year ended May 31, 2024, the Company\u00a0issued 7,566,146 performance-based RSUs. These RSUs were not considered granted for accounting purposes at the time of issuance, as the performance conditions had not yet been established or approved\u00a0and\u00a0no\u00a0amounts have been recorded within the Consolidated Statement of Income (Loss).\u00a0
\n\u00a0
\nThe Company's total stock-based compensation expense from RSUs incurred for\u00a0the\u00a0three months ended August 31, 2025\u00a0was $5,052,\u00a0compared to $6,917\u00a0for the three months ended\u00a0 August 31,\u00a02024, respectively.\u00a0
\n\u00a0
\n \n \n "}]},{"name":"rpt:f-822","factDimensions":{"xbrl:concept":"tlry:SharesAuthorizedTotal","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"1426000000"}]},{"name":"rpt:f-823","factDimensions":{"xbrl:concept":"us-gaap:CommonStockSharesAuthorized","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"1416000000"}]},{"name":"rpt:f-824","factDimensions":{"xbrl:concept":"us-gaap:PreferredStockSharesAuthorized","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"10000000"}]},{"name":"rpt:f-825","factDimensions":{"xbrl:concept":"us-gaap:CommonStockSharesIssued","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"1118291159"}]},{"name":"rpt:f-826","factDimensions":{"xbrl:concept":"us-gaap:TreasuryStockCommonShares","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"3213914"}]},{"name":"rpt:f-827","factDimensions":{"xbrl:concept":"us-gaap:PreferredStockSharesIssued","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"0","decimals":-3}]},{"name":"rpt:f-828","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesNewIssues","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares","us-gaap:SubsidiarySaleOfStockAxis":"tlry:AtthemarketProgramMember"},"factValues":[{"value":"34443799"}]},{"name":"rpt:f-829","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromIssuanceOfCommonStock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","us-gaap:SubsidiarySaleOfStockAxis":"tlry:AtthemarketProgramMember"},"factValues":[{"value":"23044000","decimals":-3}]},{"name":"rpt:f-830","factDimensions":{"xbrl:concept":"tlry:NetProceedsFromIssuanceOfCommonStock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","us-gaap:SubsidiarySaleOfStockAxis":"tlry:AtthemarketProgramMember"},"factValues":[{"value":"22491000","decimals":-3}]},{"name":"rpt:f-831","factDimensions":{"xbrl:concept":"us-gaap:PaymentsOfStockIssuanceCosts","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","us-gaap:SubsidiarySaleOfStockAxis":"tlry:AtthemarketProgramMember"},"factValues":[{"value":"553000","decimals":-3}]},{"name":"rpt:f-832","factDimensions":{"xbrl:concept":"tlry:StockIssuedDuringPeriodSharesRepurchaseOfConvertibleSecurities","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares","us-gaap:DebtConversionByUniqueDescriptionAxis":"tlry:ConversionOfTlry27NotesToSharesMember"},"factValues":[{"value":"12591816"}]},{"name":"rpt:f-833","factDimensions":{"xbrl:concept":"tlry:StockIssuedDuringPeriodValueRepurchaseOfConvertibleSecurities","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","us-gaap:DebtConversionByUniqueDescriptionAxis":"tlry:ConversionOfTlry27NotesToSharesMember"},"factValues":[{"value":"4800000","decimals":-5}]},{"name":"rpt:f-834","factDimensions":{"xbrl:concept":"tlry:DebtInstrumentAmountRepurchased","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","us-gaap:DebtConversionByUniqueDescriptionAxis":"tlry:ConversionOfTlry27NotesToSharesMember"},"factValues":[{"value":"5000000","decimals":-6}]},{"name":"rpt:f-835","factDimensions":{"xbrl:concept":"us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","us-gaap:DebtInstrumentAxis":"tlry:TLRY27Member"},"factValues":[{"value":"1158000","decimals":-3}]},{"name":"rpt:f-836","factDimensions":{"xbrl:concept":"tlry:SharesReturnedFromShareLendingAgreementTreasuryStock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares","us-gaap:DebtInstrumentAxis":"tlry:TLRY27Member"},"factValues":[{"value":"1209696"}]},{"name":"rpt:f-837","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"10576799"}]},{"name":"rpt:f-838","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares","us-gaap:AwardTypeAxis":"tlry:TimebasedRestrictedStockUnitsMember"},"factValues":[{"value":"44802378"}]},{"name":"rpt:f-839","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod","xbrl:period":"2023-06-01T00:00:00/2024-06-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares","us-gaap:AwardTypeAxis":"tlry:PerformancebasedRestrictedStockUnitsMember"},"factValues":[{"value":"7566146"}]},{"name":"rpt:f-840","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","us-gaap:AwardTypeAxis":"us-gaap:RestrictedStockUnitsRSUMember"},"factValues":[{"value":"5052000","decimals":-3}]},{"name":"rpt:f-841","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2024-06-01T00:00:00/2024-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","us-gaap:AwardTypeAxis":"us-gaap:RestrictedStockUnitsRSUMember"},"factValues":[{"value":"6917000","decimals":-3}]},{"name":"rpt:f-842","factDimensions":{"xbrl:concept":"us-gaap:ComprehensiveIncomeNoteTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \nNote 15. Accumulated other comprehensive income (loss)
\n\u00a0
\nAccumulated other comprehensive income (loss) is comprised of foreign currency translation gain (loss) as follows:
\n\u00a0
\n \n| \u00a0 | \u00a0 | Total | \u00a0 | |
| \u00a0 | \u00a0 | Foreign | \u00a0 | |
| \u00a0 | \u00a0 | currency | \u00a0 | |
| \u00a0 | \u00a0 | translation | \u00a0 | |
| \u00a0 | \u00a0 | gain (loss) | \u00a0 | |
| Balance May 31, 2024 | \u00a0 | $ | (43,499 | ) |
| Other comprehensive income (loss) | \u00a0 | \u00a0 | 3,622 | \u00a0 |
| Balance August 31, 2024 | \u00a0 | $ | (39,877 | ) |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Balance May 31, 2025 | \u00a0 | $ | (43,063 | ) |
| Other comprehensive income (loss) | \u00a0 | \u00a0 | (167 | ) |
| Balance August 31, 2025 | \u00a0 | $ | (43,230 | ) |
\u00a0
\n "}]},{"name":"rpt:f-843","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n| \u00a0 | \u00a0 | Total | \u00a0 | |
| \u00a0 | \u00a0 | Foreign | \u00a0 | |
| \u00a0 | \u00a0 | currency | \u00a0 | |
| \u00a0 | \u00a0 | translation | \u00a0 | |
| \u00a0 | \u00a0 | gain (loss) | \u00a0 | |
| Balance May 31, 2024 | \u00a0 | $ | (43,499 | ) |
| Other comprehensive income (loss) | \u00a0 | \u00a0 | 3,622 | \u00a0 |
| Balance August 31, 2024 | \u00a0 | $ | (39,877 | ) |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Balance May 31, 2025 | \u00a0 | $ | (43,063 | ) |
| Other comprehensive income (loss) | \u00a0 | \u00a0 | (167 | ) |
| Balance August 31, 2025 | \u00a0 | $ | (43,230 | ) |
Note 16. Non-controlling interests
\n\u00a0
\nThe following are majority-owned subsidiaries of the Company and the percentage of ownership interest maintained by the Company is set forth in the parenthetical:\u00a0Aphria Diamond (51%), and Colcanna S.A.S. (90%).
\n\u00a0
\nThe following table provides a summary of certain balance sheet information\u00a0before intercompany eliminations\u00a0relating to the above-referenced majority-owned subsidiaries of the Company\u00a0in which there was\u00a0a non-controlling interest as of August 31, 2025:
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \n Aphria | \n \u00a0 | \n\u00a0 | \n ColCanna | \n \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n|||
| \u00a0 | \n\u00a0 | \n Diamond | \n \u00a0 | \n\u00a0 | \n S.A.S. | \n \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n|||
| Current assets | \n \u00a0 | \n$ | \n90,684 | \n\u00a0 | \n\u00a0 | \n$ | \n5 | \n\u00a0 | \n\u00a0 | \n$ | \n90,689 | \n\u00a0 | \n
| Non-current assets | \n \u00a0 | \n\u00a0 | \n112,250 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n3,485 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n115,735 | \n\u00a0 | \n
| Current liabilities | \n \u00a0 | \n\u00a0 | \n(128,471 | \n) | \n\u00a0 | \n\u00a0 | \n(7,036 | \n) | \n\u00a0 | \n\u00a0 | \n(135,507 | \n) | \n
| Non-current liabilities | \n \u00a0 | \n\u00a0 | \n(31,408 | \n) | \n\u00a0 | \n\u00a0 | \n(1,442 | \n) | \n\u00a0 | \n\u00a0 | \n(32,850 | \n) | \n
| Net assets | \n \u00a0 | \n$ | \n43,055 | \n\u00a0 | \n\u00a0 | \n$ | \n(4,988 | \n) | \n\u00a0 | \n$ | \n38,067 | \n\u00a0 | \n
\u00a0
\nThe following table provides a summary of certain balance sheet information\u00a0before intercompany eliminations\u00a0relating to the above-referenced majority-owned subsidiaries of the Company\u00a0in which there was\u00a0a non-controlling interest as of May 31, 2025:
\n\u00a0
\n \n| \u00a0 | \u00a0 | SH | \u00a0 | \u00a0 | CC Pharma | \u00a0 | \u00a0 | Aphria | \u00a0 | \u00a0 | ColCanna | \u00a0 | \u00a0 | May 31, | \u00a0 | |||||
| \u00a0 | \u00a0 | Acquisition | \u00a0 | \u00a0 | Nordic ApS | \u00a0 | \u00a0 | Diamond | \u00a0 | \u00a0 | S.A.S. | \u00a0 | \u00a0 | 2025 | \u00a0 | |||||
| Current assets | \u00a0 | $ | \u2014 | \u00a0 | \u00a0 | $ | \u2014 | \u00a0 | \u00a0 | $ | 83,390 | \u00a0 | \u00a0 | $ | 20 | \u00a0 | \u00a0 | $ | 83,410 | \u00a0 |
| Non-current assets | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | 114,677 | \u00a0 | \u00a0 | \u00a0 | 3,348 | \u00a0 | \u00a0 | \u00a0 | 118,025 | \u00a0 |
| Current liabilities | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | (126,986 | ) | \u00a0 | \u00a0 | (6,953 | ) | \u00a0 | \u00a0 | (133,939 | ) |
| Non-current liabilities | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | (31,720 | ) | \u00a0 | \u00a0 | (1,442 | ) | \u00a0 | \u00a0 | (33,162 | ) |
| Net assets | \u00a0 | $ | \u2014 | \u00a0 | \u00a0 | $ | \u2014 | \u00a0 | \u00a0 | $ | 39,361 | \u00a0 | \u00a0 | $ | (5,027 | ) | \u00a0 | $ | 34,334 | \u00a0 |
\u00a0
\n \n \nThe following table provides a summary of certain income statement information before intercompany eliminations relating to the above referenced majority-owned subsidiaries of the Company in which there was\u00a0a non-controlling interest\u00a0for the three months ended August 31, 2025:
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \n Aphria | \n \u00a0 | \n\u00a0 | \n ColCanna | \n \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n|||
| \u00a0 | \n\u00a0 | \n Diamond | \n \u00a0 | \n\u00a0 | \n S.A.S. | \n \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n|||
| Revenue | \n \u00a0 | \n$ | \n18,102 | \n\u00a0 | \n\u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n18,102 | \n\u00a0 | \n
| Total expenses | \n \u00a0 | \n\u00a0 | \n13,497 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(186 | \n) | \n\u00a0 | \n\u00a0 | \n13,311 | \n\u00a0 | \n
| Net (loss) income | \n \u00a0 | \n\u00a0 | \n4,605 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n186 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n4,791 | \n\u00a0 | \n
| Other comprehensive (loss) income | \n \u00a0 | \n\u00a0 | \n(911 | \n) | \n\u00a0 | \n\u00a0 | \n(147 | \n) | \n\u00a0 | \n\u00a0 | \n(1,058 | \n) | \n
| Net comprehensive (loss) income | \n \u00a0 | \n$ | \n3,694 | \n\u00a0 | \n\u00a0 | \n$ | \n39 | \n\u00a0 | \n\u00a0 | \n$ | \n3,733 | \n\u00a0 | \n
| Non-controlling interest % | \n \u00a0 | \n\u00a0 | \n49 | \n% | \n\u00a0 | \n\u00a0 | \n10 | \n% | \n\u00a0 | \n NA | \n \u00a0 | \n|
| Comprehensive (loss) income attributable to NCI | \n \u00a0 | \n\u00a0 | \n1,810 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n4 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n1,814 | \n\u00a0 | \n
| Net comprehensive (loss) income attributable to NCI | \n \u00a0 | \n$ | \n1,810 | \n\u00a0 | \n\u00a0 | \n$ | \n4 | \n\u00a0 | \n\u00a0 | \n$ | \n1,814 | \n\u00a0 | \n
\u00a0
\nThe following table provides a summary of certain income statement information before intercompany eliminations relating to the above referenced majority-owned subsidiaries of the Company in which there was\u00a0a non-controlling interest\u00a0for the three months ended August 31,\u00a02024:
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \n SH | \n \u00a0 | \n\u00a0 | \n CC Pharma | \n \u00a0 | \n\u00a0 | \n Aphria | \n \u00a0 | \n\u00a0 | \n ColCanna | \n \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n|||||
| \u00a0 | \n\u00a0 | \n Acquisition | \n \u00a0 | \n\u00a0 | \n Nordic ApS | \n \u00a0 | \n\u00a0 | \n Diamond | \n \u00a0 | \n\u00a0 | \n S.A.S. | \n \u00a0 | \n\u00a0 | \n 2024 | \n \u00a0 | \n|||||
| Revenue | \n \u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n18,558 | \n\u00a0 | \n\u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n18,558 | \n\u00a0 | \n
| Total expenses | \n \u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n5 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n9,216 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n630 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n9,851 | \n\u00a0 | \n
| Net (loss) income | \n \u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(5 | \n) | \n\u00a0 | \n\u00a0 | \n9,342 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(630 | \n) | \n\u00a0 | \n\u00a0 | \n8,707 | \n\u00a0 | \n
| Other comprehensive (loss) income | \n \u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(1 | \n) | \n\u00a0 | \n\u00a0 | \n1,041 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n277 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n1,317 | \n\u00a0 | \n
| Net comprehensive (loss) income | \n \u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n(6 | \n) | \n\u00a0 | \n$ | \n10,383 | \n\u00a0 | \n\u00a0 | \n$ | \n(353 | \n) | \n\u00a0 | \n$ | \n10,024 | \n\u00a0 | \n
| Non-controlling interest % | \n \u00a0 | \n\u00a0 | \n32 | \n% | \n\u00a0 | \n\u00a0 | \n25 | \n% | \n\u00a0 | \n\u00a0 | \n49 | \n% | \n\u00a0 | \n\u00a0 | \n10 | \n% | \n\u00a0 | \n NA | \n \u00a0 | \n|
| Comprehensive (loss) income attributable to NCI | \n \u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(2 | \n) | \n\u00a0 | \n\u00a0 | \n5,088 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(35 | \n) | \n\u00a0 | \n\u00a0 | \n5,051 | \n\u00a0 | \n
| Net comprehensive (loss) income attributable to NCI | \n \u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n(2 | \n) | \n\u00a0 | \n$ | \n5,088 | \n\u00a0 | \n\u00a0 | \n$ | \n(35 | \n) | \n\u00a0 | \n$ | \n5,051 | \n\u00a0 | \n
\u00a0 \u00a0 \u00a0\u00a0
\n "}]},{"name":"rpt:f-851","factDimensions":{"xbrl:concept":"us-gaap:MinorityInterestOwnershipPercentageByParent","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","srt:OwnershipAxis":"tlry:AphriaDiamondMember"},"factValues":[{"value":"0.51","decimals":2}]},{"name":"rpt:f-852","factDimensions":{"xbrl:concept":"us-gaap:MinorityInterestOwnershipPercentageByParent","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","srt:OwnershipAxis":"tlry:ColCannaSASMember"},"factValues":[{"value":"0.90","decimals":1}]},{"name":"rpt:f-853","factDimensions":{"xbrl:concept":"srt:ScheduleOfCondensedBalanceSheetTableTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n| \u00a0 | \n\u00a0 | \n Aphria | \n \u00a0 | \n\u00a0 | \n ColCanna | \n \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n|||
| \u00a0 | \n\u00a0 | \n Diamond | \n \u00a0 | \n\u00a0 | \n S.A.S. | \n \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n|||
| Current assets | \n \u00a0 | \n$ | \n90,684 | \n\u00a0 | \n\u00a0 | \n$ | \n5 | \n\u00a0 | \n\u00a0 | \n$ | \n90,689 | \n\u00a0 | \n
| Non-current assets | \n \u00a0 | \n\u00a0 | \n112,250 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n3,485 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n115,735 | \n\u00a0 | \n
| Current liabilities | \n \u00a0 | \n\u00a0 | \n(128,471 | \n) | \n\u00a0 | \n\u00a0 | \n(7,036 | \n) | \n\u00a0 | \n\u00a0 | \n(135,507 | \n) | \n
| Non-current liabilities | \n \u00a0 | \n\u00a0 | \n(31,408 | \n) | \n\u00a0 | \n\u00a0 | \n(1,442 | \n) | \n\u00a0 | \n\u00a0 | \n(32,850 | \n) | \n
| Net assets | \n \u00a0 | \n$ | \n43,055 | \n\u00a0 | \n\u00a0 | \n$ | \n(4,988 | \n) | \n\u00a0 | \n$ | \n38,067 | \n\u00a0 | \n
| \u00a0 | \u00a0 | SH | \u00a0 | \u00a0 | CC Pharma | \u00a0 | \u00a0 | Aphria | \u00a0 | \u00a0 | ColCanna | \u00a0 | \u00a0 | May 31, | \u00a0 | |||||
| \u00a0 | \u00a0 | Acquisition | \u00a0 | \u00a0 | Nordic ApS | \u00a0 | \u00a0 | Diamond | \u00a0 | \u00a0 | S.A.S. | \u00a0 | \u00a0 | 2025 | \u00a0 | |||||
| Current assets | \u00a0 | $ | \u2014 | \u00a0 | \u00a0 | $ | \u2014 | \u00a0 | \u00a0 | $ | 83,390 | \u00a0 | \u00a0 | $ | 20 | \u00a0 | \u00a0 | $ | 83,410 | \u00a0 |
| Non-current assets | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | 114,677 | \u00a0 | \u00a0 | \u00a0 | 3,348 | \u00a0 | \u00a0 | \u00a0 | 118,025 | \u00a0 |
| Current liabilities | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | (126,986 | ) | \u00a0 | \u00a0 | (6,953 | ) | \u00a0 | \u00a0 | (133,939 | ) |
| Non-current liabilities | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | (31,720 | ) | \u00a0 | \u00a0 | (1,442 | ) | \u00a0 | \u00a0 | (33,162 | ) |
| Net assets | \u00a0 | $ | \u2014 | \u00a0 | \u00a0 | $ | \u2014 | \u00a0 | \u00a0 | $ | 39,361 | \u00a0 | \u00a0 | $ | (5,027 | ) | \u00a0 | $ | 34,334 | \u00a0 |
| \u00a0 | \n\u00a0 | \n Aphria | \n \u00a0 | \n\u00a0 | \n ColCanna | \n \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n|||
| \u00a0 | \n\u00a0 | \n Diamond | \n \u00a0 | \n\u00a0 | \n S.A.S. | \n \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n|||
| Revenue | \n \u00a0 | \n$ | \n18,102 | \n\u00a0 | \n\u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n18,102 | \n\u00a0 | \n
| Total expenses | \n \u00a0 | \n\u00a0 | \n13,497 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(186 | \n) | \n\u00a0 | \n\u00a0 | \n13,311 | \n\u00a0 | \n
| Net (loss) income | \n \u00a0 | \n\u00a0 | \n4,605 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n186 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n4,791 | \n\u00a0 | \n
| Other comprehensive (loss) income | \n \u00a0 | \n\u00a0 | \n(911 | \n) | \n\u00a0 | \n\u00a0 | \n(147 | \n) | \n\u00a0 | \n\u00a0 | \n(1,058 | \n) | \n
| Net comprehensive (loss) income | \n \u00a0 | \n$ | \n3,694 | \n\u00a0 | \n\u00a0 | \n$ | \n39 | \n\u00a0 | \n\u00a0 | \n$ | \n3,733 | \n\u00a0 | \n
| Non-controlling interest % | \n \u00a0 | \n\u00a0 | \n49 | \n% | \n\u00a0 | \n\u00a0 | \n10 | \n% | \n\u00a0 | \n NA | \n \u00a0 | \n|
| Comprehensive (loss) income attributable to NCI | \n \u00a0 | \n\u00a0 | \n1,810 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n4 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n1,814 | \n\u00a0 | \n
| Net comprehensive (loss) income attributable to NCI | \n \u00a0 | \n$ | \n1,810 | \n\u00a0 | \n\u00a0 | \n$ | \n4 | \n\u00a0 | \n\u00a0 | \n$ | \n1,814 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n SH | \n \u00a0 | \n\u00a0 | \n CC Pharma | \n \u00a0 | \n\u00a0 | \n Aphria | \n \u00a0 | \n\u00a0 | \n ColCanna | \n \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n|||||
| \u00a0 | \n\u00a0 | \n Acquisition | \n \u00a0 | \n\u00a0 | \n Nordic ApS | \n \u00a0 | \n\u00a0 | \n Diamond | \n \u00a0 | \n\u00a0 | \n S.A.S. | \n \u00a0 | \n\u00a0 | \n 2024 | \n \u00a0 | \n|||||
| Revenue | \n \u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n18,558 | \n\u00a0 | \n\u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n18,558 | \n\u00a0 | \n
| Total expenses | \n \u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n5 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n9,216 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n630 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n9,851 | \n\u00a0 | \n
| Net (loss) income | \n \u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(5 | \n) | \n\u00a0 | \n\u00a0 | \n9,342 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(630 | \n) | \n\u00a0 | \n\u00a0 | \n8,707 | \n\u00a0 | \n
| Other comprehensive (loss) income | \n \u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(1 | \n) | \n\u00a0 | \n\u00a0 | \n1,041 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n277 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n1,317 | \n\u00a0 | \n
| Net comprehensive (loss) income | \n \u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n(6 | \n) | \n\u00a0 | \n$ | \n10,383 | \n\u00a0 | \n\u00a0 | \n$ | \n(353 | \n) | \n\u00a0 | \n$ | \n10,024 | \n\u00a0 | \n
| Non-controlling interest % | \n \u00a0 | \n\u00a0 | \n32 | \n% | \n\u00a0 | \n\u00a0 | \n25 | \n% | \n\u00a0 | \n\u00a0 | \n49 | \n% | \n\u00a0 | \n\u00a0 | \n10 | \n% | \n\u00a0 | \n NA | \n \u00a0 | \n|
| Comprehensive (loss) income attributable to NCI | \n \u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(2 | \n) | \n\u00a0 | \n\u00a0 | \n5,088 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(35 | \n) | \n\u00a0 | \n\u00a0 | \n5,051 | \n\u00a0 | \n
| Net comprehensive (loss) income attributable to NCI | \n \u00a0 | \n$ | \n\u2014 | \n\u00a0 | \n\u00a0 | \n$ | \n(2 | \n) | \n\u00a0 | \n$ | \n5,088 | \n\u00a0 | \n\u00a0 | \n$ | \n(35 | \n) | \n\u00a0 | \n$ | \n5,051 | \n\u00a0 | \n
Note 17. Income taxes
\n\u00a0
\nThe determination of the Company\u2019s overall effective\u00a0tax\u00a0rate requires significant judgment, the use of estimates, and the interpretation and application of complex\u00a0tax\u00a0laws. The effective\u00a0tax\u00a0rate reflects the income earned and taxed in various United States federal, state, and foreign jurisdictions.\u00a0Tax\u00a0law changes, increases, and decreases in temporary and permanent differences between book and\u00a0tax\u00a0items, valuation allowances against the deferred tax assets, stock compensation, and the Company\u2019s change in income in each jurisdiction all affect the overall effective\u00a0tax\u00a0rate. It is the Company\u2019s practice to recognize interest and penalties related to uncertain\u00a0tax\u00a0positions in income\u00a0tax\u00a0expense.
\n\u00a0
\nThe Company reported income tax recovery\u00a0of $2,285 for the three months ended August 31, 2025, and income tax expense of $886 for the three months ended August 31,\u00a02024. The income tax benefit\u00a0in the current period varies from the US statutory income tax rate and prior year period primarily due to the geographical mix of earnings and losses with no tax benefit resulting from valuation allowances in certain jurisdictions.
\n\u00a0
\n \n \n "}]},{"name":"rpt:f-958","factDimensions":{"xbrl:concept":"us-gaap:IncomeTaxExpenseBenefit","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-2285000","decimals":-3}]},{"name":"rpt:f-959","factDimensions":{"xbrl:concept":"us-gaap:IncomeTaxExpenseBenefit","xbrl:period":"2024-06-01T00:00:00/2024-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"886000","decimals":-3}]},{"name":"rpt:f-960","factDimensions":{"xbrl:concept":"us-gaap:CommitmentsAndContingenciesDisclosureTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \nNote 18. Commitments and contingencies
\n\u00a0
\nPurchase and other commitments
\n\u00a0
\nThe Company has financial commitments\u00a0on long-term debt, refer to Note 11\u00a0(Long-term debt), convertible notes, refer to Note 12\u00a0(Convertible debentures payable), material purchase commitments inclusive of\u00a0multi-period\u00a0sponsorship rights and construction commitments as follows:
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \n Total | \n \u00a0 | \n\u00a0 | \n 2026 | \n \u00a0 | \n\u00a0 | \n 2027 | \n \u00a0 | \n\u00a0 | \n 2028 | \n \u00a0 | \n\u00a0 | \n 2029 | \n \u00a0 | \n\u00a0 | \n Thereafter | \n \u00a0 | \n||||||
| Long-term debt repayment | \n \u00a0 | \n$ | \n161,572 | \n\u00a0 | \n\u00a0 | \n$ | \n16,295 | \n\u00a0 | \n\u00a0 | \n$ | \n16,241 | \n\u00a0 | \n\u00a0 | \n$ | \n96,436 | \n\u00a0 | \n\u00a0 | \n$ | \n3,531 | \n\u00a0 | \n\u00a0 | \n$ | \n29,069 | \n\u00a0 | \n
| Convertible debentures payable | \n \u00a0 | \n\u00a0 | \n100,000 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n100,000 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n
| Material purchase obligations | \n \u00a0 | \n\u00a0 | \n73,691 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n41,073 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n26,580 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n6,038 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n
| Construction commitments | \n \u00a0 | \n\u00a0 | \n888 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n888 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n
| Total | \n \u00a0 | \n$ | \n336,151 | \n\u00a0 | \n\u00a0 | \n$ | \n58,256 | \n\u00a0 | \n\u00a0 | \n$ | \n42,821 | \n\u00a0 | \n\u00a0 | \n$ | \n202,474 | \n\u00a0 | \n\u00a0 | \n$ | \n3,531 | \n\u00a0 | \n\u00a0 | \n$ | \n29,069 | \n\u00a0 | \n
\u00a0
\nLegal proceedings
\n\u00a0
\nIn the ordinary course of business, we are at times subject to various legal proceedings and disputes, including the proceedings specifically discussed below. We assess our liabilities and contingencies in connection with outstanding legal proceedings utilizing the latest information available. Where it is probable that we will incur a loss and the amount of the loss can be reasonably estimated, we record a liability in our consolidated financial statements. These legal reserves\u00a0 may\u00a0be increased or decreased to reflect any relevant developments on a quarterly basis. Where a loss is\u00a0not\u00a0probable or the amount of loss is\u00a0not\u00a0estimable, we do\u00a0not\u00a0accrue legal reserves. While the outcome of legal proceedings is inherently uncertain, based on information currently available and available insurance coverage, our management believes that it has established appropriate legal reserves. Any incremental liabilities arising from pending legal proceedings are\u00a0not\u00a0expected to have a material adverse effect on our consolidated financial position, consolidated results of operations, or consolidated cash flows. However, it is possible that the ultimate resolution of these matters, if unfavorable,\u00a0 may\u00a0be material to our consolidated financial position, consolidated results of operations, or consolidated cash flows.
\n\u00a0
\nThere have been no material changes in\u00a0the legal proceedings since\u00a0our Annual Report on Form 10-K\u00a0for the fiscal year ended May 31, 2025.
\n\u00a0
\nSummary of litigation accruals\u00a0
\n\u00a0
\nAs described in Note 10\u00a0(Accounts payable and accrued liabilities), the total estimated litigation\u00a0expense accrual included in accrued liabilities as of\u00a0 August 31, 2025\u00a0and May 31, 2025\u00a0was\u00a0$12,021\u00a0and\u00a0$12,431, respectively. This estimated accrual is intended to cover various ongoing litigation matters with probable losses that can be reasonably estimated.
\n\u00a0
\n \n \n "}]},{"name":"rpt:f-961","factDimensions":{"xbrl:concept":"srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n| \u00a0 | \n\u00a0 | \n Total | \n \u00a0 | \n\u00a0 | \n 2026 | \n \u00a0 | \n\u00a0 | \n 2027 | \n \u00a0 | \n\u00a0 | \n 2028 | \n \u00a0 | \n\u00a0 | \n 2029 | \n \u00a0 | \n\u00a0 | \n Thereafter | \n \u00a0 | \n||||||
| Long-term debt repayment | \n \u00a0 | \n$ | \n161,572 | \n\u00a0 | \n\u00a0 | \n$ | \n16,295 | \n\u00a0 | \n\u00a0 | \n$ | \n16,241 | \n\u00a0 | \n\u00a0 | \n$ | \n96,436 | \n\u00a0 | \n\u00a0 | \n$ | \n3,531 | \n\u00a0 | \n\u00a0 | \n$ | \n29,069 | \n\u00a0 | \n
| Convertible debentures payable | \n \u00a0 | \n\u00a0 | \n100,000 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n100,000 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n
| Material purchase obligations | \n \u00a0 | \n\u00a0 | \n73,691 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n41,073 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n26,580 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n6,038 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n
| Construction commitments | \n \u00a0 | \n\u00a0 | \n888 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n888 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u2014 | \n\u00a0 | \n
| Total | \n \u00a0 | \n$ | \n336,151 | \n\u00a0 | \n\u00a0 | \n$ | \n58,256 | \n\u00a0 | \n\u00a0 | \n$ | \n42,821 | \n\u00a0 | \n\u00a0 | \n$ | \n202,474 | \n\u00a0 | \n\u00a0 | \n$ | \n3,531 | \n\u00a0 | \n\u00a0 | \n$ | \n29,069 | \n\u00a0 | \n
Note 19. Net revenue
\n\u00a0
\nThe Company reports Net revenue in\u00a0\u00a0reporting segments: beverage, cannabis, distribution, and wellness. Net revenue for the\u00a0three months ended August 31, 2025\u00a0and August 31, 2024\u00a0were as follows:
\n\u00a0
\n \n| \u00a0 | \u00a0 | For the three months ended | \u00a0 | |||||
| \u00a0 | \u00a0 | August 31, | \u00a0 | \u00a0 | August 31, | \u00a0 | ||
| \u00a0 | \u00a0 | 2025 | \u00a0 | \u00a0 | 2024 | \u00a0 | ||
| Beverage revenue | \u00a0 | $ | 58,512 | \u00a0 | \u00a0 | $ | 59,163 | \u00a0 |
| Beverage excise taxes | \u00a0 | \u00a0 | (2,773 | ) | \u00a0 | \u00a0 | (3,191 | ) |
| Net beverage revenue | \u00a0 | \u00a0 | 55,739 | \u00a0 | \u00a0 | \u00a0 | 55,972 | \u00a0 |
| Cannabis revenue | \u00a0 | \u00a0 | 87,735 | \u00a0 | \u00a0 | \u00a0 | 81,194 | \u00a0 |
| Cannabis excise taxes | \u00a0 | \u00a0 | (23,224 | ) | \u00a0 | \u00a0 | (19,945 | ) |
| Net cannabis revenue | \u00a0 | \u00a0 | 64,511 | \u00a0 | \u00a0 | \u00a0 | 61,249 | \u00a0 |
| Distribution revenue | \u00a0 | \u00a0 | 74,007 | \u00a0 | \u00a0 | \u00a0 | 68,071 | \u00a0 |
| Wellness revenue | \u00a0 | \u00a0 | 15,244 | \u00a0 | \u00a0 | \u00a0 | 14,752 | \u00a0 |
| Total | \u00a0 | $ | 209,501 | \u00a0 | \u00a0 | $ | 200,044 | \u00a0 |
\u00a0\u00a0
\n "}]},{"name":"rpt:f-995","factDimensions":{"xbrl:concept":"us-gaap:DisaggregationOfRevenueTableTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n| \u00a0 | \u00a0 | For the three months ended | \u00a0 | |||||
| \u00a0 | \u00a0 | August 31, | \u00a0 | \u00a0 | August 31, | \u00a0 | ||
| \u00a0 | \u00a0 | 2025 | \u00a0 | \u00a0 | 2024 | \u00a0 | ||
| Beverage revenue | \u00a0 | $ | 58,512 | \u00a0 | \u00a0 | $ | 59,163 | \u00a0 |
| Beverage excise taxes | \u00a0 | \u00a0 | (2,773 | ) | \u00a0 | \u00a0 | (3,191 | ) |
| Net beverage revenue | \u00a0 | \u00a0 | 55,739 | \u00a0 | \u00a0 | \u00a0 | 55,972 | \u00a0 |
| Cannabis revenue | \u00a0 | \u00a0 | 87,735 | \u00a0 | \u00a0 | \u00a0 | 81,194 | \u00a0 |
| Cannabis excise taxes | \u00a0 | \u00a0 | (23,224 | ) | \u00a0 | \u00a0 | (19,945 | ) |
| Net cannabis revenue | \u00a0 | \u00a0 | 64,511 | \u00a0 | \u00a0 | \u00a0 | 61,249 | \u00a0 |
| Distribution revenue | \u00a0 | \u00a0 | 74,007 | \u00a0 | \u00a0 | \u00a0 | 68,071 | \u00a0 |
| Wellness revenue | \u00a0 | \u00a0 | 15,244 | \u00a0 | \u00a0 | \u00a0 | 14,752 | \u00a0 |
| Total | \u00a0 | $ | 209,501 | \u00a0 | \u00a0 | $ | 200,044 | \u00a0 |
Note 20. Cost of goods sold
\n\u00a0
\nThe Company reports Cost of goods sold in\u00a0\u00a0reporting segments: beverage, cannabis, distribution, and wellness.\u00a0Cost of goods sold for the\u00a0three months ended August 31, 2025\u00a0and August 31, 2024\u00a0were as follows:
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \n For the three months ended | \n \u00a0 | \n|||||
| \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n||
| \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n\u00a0 | \n 2024 | \n \u00a0 | \n||
| Beverage costs | \n \u00a0 | \n\u00a0 | \n34,413 | \n\u00a0 | \n\u00a0 | \n$ | \n33,050 | \n\u00a0 | \n
| Cannabis costs | \n \u00a0 | \n\u00a0 | \n41,241 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n37,054 | \n\u00a0 | \n
| Distribution costs | \n \u00a0 | \n\u00a0 | \n66,008 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n60,138 | \n\u00a0 | \n
| Wellness costs | \n \u00a0 | \n\u00a0 | \n10,370 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n10,096 | \n\u00a0 | \n
| Total | \n \u00a0 | \n$ | \n152,032 | \n\u00a0 | \n\u00a0 | \n$ | \n140,338 | \n\u00a0 | \n
\u00a0 \u00a0 \u00a0
\n "}]},{"name":"rpt:f-1015","factDimensions":{"xbrl:concept":"tlry:ScheduleOfCostOfGoodsSoldTableTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n| \u00a0 | \n\u00a0 | \n For the three months ended | \n \u00a0 | \n|||||
| \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n||
| \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n\u00a0 | \n 2024 | \n \u00a0 | \n||
| Beverage costs | \n \u00a0 | \n\u00a0 | \n34,413 | \n\u00a0 | \n\u00a0 | \n$ | \n33,050 | \n\u00a0 | \n
| Cannabis costs | \n \u00a0 | \n\u00a0 | \n41,241 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n37,054 | \n\u00a0 | \n
| Distribution costs | \n \u00a0 | \n\u00a0 | \n66,008 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n60,138 | \n\u00a0 | \n
| Wellness costs | \n \u00a0 | \n\u00a0 | \n10,370 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n10,096 | \n\u00a0 | \n
| Total | \n \u00a0 | \n$ | \n152,032 | \n\u00a0 | \n\u00a0 | \n$ | \n140,338 | \n\u00a0 | \n
Note 21. General and administrative expenses
\n\u00a0
\nGeneral and administrative expenses\u00a0for the\u00a0three months ended August 31, 2025\u00a0and August 31, 2024\u00a0were as follows:
\n\u00a0
\n \n| \u00a0 | \u00a0 | For the three months ended | \u00a0 | |||||
| \u00a0 | \u00a0 | August 31, | \u00a0 | \u00a0 | August 31, | \u00a0 | ||
| \u00a0 | \u00a0 | 2025 | \u00a0 | \u00a0 | 2024 | \u00a0 | ||
| Salaries and wages | \u00a0 | $ | 21,736 | \u00a0 | \u00a0 | \u00a0 | 21,567 | \u00a0 |
| Office and general | \u00a0 | \u00a0 | 8,697 | \u00a0 | \u00a0 | \u00a0 | 9,260 | \u00a0 |
| Stock-based compensation | \u00a0 | \u00a0 | 5,052 | \u00a0 | \u00a0 | \u00a0 | 6,917 | \u00a0 |
| Insurance | \u00a0 | \u00a0 | 2,393 | \u00a0 | \u00a0 | \u00a0 | 2,455 | \u00a0 |
| Professional fees | \u00a0 | \u00a0 | 1,218 | \u00a0 | \u00a0 | \u00a0 | 1,178 | \u00a0 |
| Gain on sale of capital assets | \u00a0 | \u00a0 | (241 | ) | \u00a0 | \u00a0 | (26 | ) |
| Travel and accommodation | \u00a0 | \u00a0 | 1,312 | \u00a0 | \u00a0 | \u00a0 | 1,493 | \u00a0 |
| Rent | \u00a0 | \u00a0 | 886 | \u00a0 | \u00a0 | \u00a0 | 1,269 | \u00a0 |
| Total | \u00a0 | $ | 41,053 | \u00a0 | \u00a0 | $ | 44,113 | \u00a0 |
\u00a0
\n \n \n "}]},{"name":"rpt:f-1027","factDimensions":{"xbrl:concept":"tlry:ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n| \u00a0 | \u00a0 | For the three months ended | \u00a0 | |||||
| \u00a0 | \u00a0 | August 31, | \u00a0 | \u00a0 | August 31, | \u00a0 | ||
| \u00a0 | \u00a0 | 2025 | \u00a0 | \u00a0 | 2024 | \u00a0 | ||
| Salaries and wages | \u00a0 | $ | 21,736 | \u00a0 | \u00a0 | \u00a0 | 21,567 | \u00a0 |
| Office and general | \u00a0 | \u00a0 | 8,697 | \u00a0 | \u00a0 | \u00a0 | 9,260 | \u00a0 |
| Stock-based compensation | \u00a0 | \u00a0 | 5,052 | \u00a0 | \u00a0 | \u00a0 | 6,917 | \u00a0 |
| Insurance | \u00a0 | \u00a0 | 2,393 | \u00a0 | \u00a0 | \u00a0 | 2,455 | \u00a0 |
| Professional fees | \u00a0 | \u00a0 | 1,218 | \u00a0 | \u00a0 | \u00a0 | 1,178 | \u00a0 |
| Gain on sale of capital assets | \u00a0 | \u00a0 | (241 | ) | \u00a0 | \u00a0 | (26 | ) |
| Travel and accommodation | \u00a0 | \u00a0 | 1,312 | \u00a0 | \u00a0 | \u00a0 | 1,493 | \u00a0 |
| Rent | \u00a0 | \u00a0 | 886 | \u00a0 | \u00a0 | \u00a0 | 1,269 | \u00a0 |
| Total | \u00a0 | $ | 41,053 | \u00a0 | \u00a0 | $ | 44,113 | \u00a0 |
Note 22. Restructuring charges
\n\u00a0
\nIn connection with the integration of certain acquisitions and strategic transactions, the Company has incurred restructuring and exit costs in the amount of\u00a0$869\u00a0for the three months ended August 31, 2025, compared to $4,247\u00a0for the prior year period. All restructuring\u00a0plans are approved at the executive level, and their associated expenses are recognized in\u00a0the period in which the plan is\u00a0committed or otherwise incurred.
\n\u00a0
\nWithin the Cannabis segment,\u00a0during\u00a0the three months ended August 31, 2025, the Company recognized\u00a0$692 of expenses related to employee termination severance and benefits associated with the reorganization of the Canadian cannabis commercial function.\u00a0Additionally, the Company recognized $177 of restructuring charges related to our decision to exit the New Zealand medical cannabis market announced during the fiscal year ended\u00a0 May 31, 2025.\u00a0
\n\u00a0
\nDuring the fiscal year ended May 31, 2025, the Company accrued $8,500 of restructuring\u00a0charges related to the closure of Hop Valley and other Project 420\u00a0initiatives within the Beverage segment, of which $1,249\u00a0was recognized in the three months ended August 31, 2025 thereby, reducing the accrual to $7,251.\u00a0\u00a0
\n\u00a0
\n "}]},{"name":"rpt:f-1047","factDimensions":{"xbrl:concept":"us-gaap:RestructuringCosts","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"869000","decimals":-3}]},{"name":"rpt:f-1048","factDimensions":{"xbrl:concept":"us-gaap:RestructuringCosts","xbrl:period":"2024-06-01T00:00:00/2024-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4247000","decimals":-3}]},{"name":"rpt:f-1049","factDimensions":{"xbrl:concept":"us-gaap:RestructuringCosts","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","us-gaap:RestructuringCostAndReserveAxis":"us-gaap:EmployeeSeveranceMember","us-gaap:StatementBusinessSegmentsAxis":"tlry:CannabisSegmentMember"},"factValues":[{"value":"692000","decimals":-3}]},{"name":"rpt:f-1050","factDimensions":{"xbrl:concept":"us-gaap:RestructuringCosts","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","us-gaap:RestructuringCostAndReserveAxis":"us-gaap:FacilityClosingMember","us-gaap:StatementBusinessSegmentsAxis":"tlry:CannabisSegmentMember","srt:StatementGeographicalAxis":"country:NZ"},"factValues":[{"value":"177000","decimals":-3}]},{"name":"rpt:f-1051","factDimensions":{"xbrl:concept":"us-gaap:RestructuringCosts","xbrl:period":"2024-06-01T00:00:00/2025-06-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","us-gaap:PropertyPlantAndEquipmentByTypeAxis":"tlry:HopValleyMember","us-gaap:RestructuringCostAndReserveAxis":"us-gaap:FacilityClosingMember","us-gaap:StatementBusinessSegmentsAxis":"tlry:CannabisSegmentMember"},"factValues":[{"value":"8500000","decimals":-5}]},{"name":"rpt:f-1052","factDimensions":{"xbrl:concept":"us-gaap:RestructuringCosts","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","us-gaap:PropertyPlantAndEquipmentByTypeAxis":"tlry:HopValleyMember","us-gaap:RestructuringCostAndReserveAxis":"us-gaap:FacilityClosingMember","us-gaap:StatementBusinessSegmentsAxis":"tlry:CannabisSegmentMember"},"factValues":[{"value":"1249000","decimals":-3}]},{"name":"rpt:f-1053","factDimensions":{"xbrl:concept":"us-gaap:RestructuringReserveAccrualAdjustment1","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","us-gaap:PropertyPlantAndEquipmentByTypeAxis":"tlry:HopValleyMember","us-gaap:RestructuringCostAndReserveAxis":"us-gaap:FacilityClosingMember","us-gaap:StatementBusinessSegmentsAxis":"tlry:CannabisSegmentMember"},"factValues":[{"value":"7251000","decimals":-3}]},{"name":"rpt:f-1054","factDimensions":{"xbrl:concept":"us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \nNote 23. Non-operating income (expense), net
\n\u00a0
\nNon-operating income (expense), net for the\u00a0three months ended August 31, 2025\u00a0and August 31, 2024\u00a0were as follows:
\n\u00a0
\n \n| \u00a0 | \u00a0 | For the three months ended | \u00a0 | |||||
| \u00a0 | \u00a0 | August 31, | \u00a0 | \u00a0 | August 31, | \u00a0 | ||
| \u00a0 | \u00a0 | 2025 | \u00a0 | \u00a0 | 2024 | \u00a0 | ||
| Change in fair value of warrant liability | \u00a0 | \u00a0 | (3,670 | ) | \u00a0 | \u00a0 | 696 | \u00a0 |
| Foreign exchange gain (loss) | \u00a0 | \u00a0 | 6,928 | \u00a0 | \u00a0 | \u00a0 | 11,881 | \u00a0 |
| (Loss) gain on long-term investments | \u00a0 | \u00a0 | 39 | \u00a0 | \u00a0 | \u00a0 | (39 | ) |
| Unrealized loss on digital assets | \u00a0 | \u00a0 | (8 | ) | \u00a0 | \u00a0 | \u2014 | \u00a0 |
| Other non-operating (losses) gains, net | \u00a0 | \u00a0 | 543 | \u00a0 | \u00a0 | \u00a0 | 108 | \u00a0 |
| Total | \u00a0 | $ | 3,832 | \u00a0 | \u00a0 | $ | 12,646 | \u00a0 |
\u00a0
\nThe other non-operating losses\u00a0(gains), net for the\u00a0three months ended August 31, 2025, were losses of $543\u00a0which was\u00a0mainly\u00a0comprised of the $495 gain resulting from the exchange transaction of\u00a0the TLRY\u00a027\u00a0Note, as described in Note 12 (Convertible debentures payable).\u00a0
\n "}]},{"name":"rpt:f-1055","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n| \u00a0 | \u00a0 | For the three months ended | \u00a0 | |||||
| \u00a0 | \u00a0 | August 31, | \u00a0 | \u00a0 | August 31, | \u00a0 | ||
| \u00a0 | \u00a0 | 2025 | \u00a0 | \u00a0 | 2024 | \u00a0 | ||
| Change in fair value of warrant liability | \u00a0 | \u00a0 | (3,670 | ) | \u00a0 | \u00a0 | 696 | \u00a0 |
| Foreign exchange gain (loss) | \u00a0 | \u00a0 | 6,928 | \u00a0 | \u00a0 | \u00a0 | 11,881 | \u00a0 |
| (Loss) gain on long-term investments | \u00a0 | \u00a0 | 39 | \u00a0 | \u00a0 | \u00a0 | (39 | ) |
| Unrealized loss on digital assets | \u00a0 | \u00a0 | (8 | ) | \u00a0 | \u00a0 | \u2014 | \u00a0 |
| Other non-operating (losses) gains, net | \u00a0 | \u00a0 | 543 | \u00a0 | \u00a0 | \u00a0 | 108 | \u00a0 |
| Total | \u00a0 | $ | 3,832 | \u00a0 | \u00a0 | $ | 12,646 | \u00a0 |
Note 24. Financial risk management and financial instruments
\n\u00a0
\nFinancial instruments
\n\u00a0
\nThe Company's classification of its financial instruments is described in Note 3\u00a0(Significant accounting policies) in the Notes to our Annual Financial Statements.
\n\u00a0
\nThe carrying values of marketable securities, accounts receivable, bank indebtedness and accounts payable and accrued liabilities approximate their fair values due to their short periods to maturity.
\n\u00a0
\nOn\u00a0 August 31, 2025\u00a0and\u00a0 May 31, 2025, the Company had long-term debt of $2,437 and $2,546, respectively,\u00a0and the principal portion of convertible debentures payable of $100,000 and $105,000, respectively,\u00a0subject to fixed interest rates. The Company\u2019s long-term debt is valued based on discounting the future cash outflows associated with the long-term debt. The discount rate is based on the incremental premium above market rates for the U.S. Department of the Treasury securities of similar duration. In each period thereafter, the incremental premium is held constant while the U.S. Department of the Treasury security is based on the then current market value to derive the discount rate.
\n\u00a0
\n \n \nThe following tables present information about the Company\u2019s assets and liabilities that are measured at fair value on a recurring basis as of August 31, 2025 and\u00a0 May 31, 2025 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value:
\n\u00a0
\n \n| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | August 31, | \u00a0 | |
| \u00a0 | \u00a0 | Level 1 | \u00a0 | \u00a0 | Level 2 | \u00a0 | \u00a0 | Level 3 | \u00a0 | \u00a0 | 2025 | \u00a0 | ||||
| Financial assets | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Cash and cash equivalents | \u00a0 | $ | 264,828 | \u00a0 | \u00a0 | $ | \u2014 | \u00a0 | \u00a0 | $ | \u2014 | \u00a0 | \u00a0 | $ | 264,828 | \u00a0 |
| Equity investments measured at fair value | \u00a0 | \u00a0 | 995 | \u00a0 | \u00a0 | \u00a0 | 1,017 | \u00a0 | \u00a0 | \u00a0 | 8,160 | \u00a0 | \u00a0 | \u00a0 | 10,172 | \u00a0 |
| Digital assets | \u00a0 | \u00a0 | 992 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | 992 | \u00a0 |
| Financial liabilities | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Warrant liability | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | (4,762 | ) | \u00a0 | \u00a0 | (4,762 | ) |
| Contingent consideration | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 |
| Total recurring fair value measurements | \u00a0 | $ | 266,815 | \u00a0 | \u00a0 | $ | 1,017 | \u00a0 | \u00a0 | $ | 3,398 | \u00a0 | \u00a0 | $ | 271,230 | \u00a0 |
\u00a0
\n \n| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | May 31, | \u00a0 | |
| \u00a0 | \u00a0 | Level 1 | \u00a0 | \u00a0 | Level 2 | \u00a0 | \u00a0 | Level 3 | \u00a0 | \u00a0 | 2025 | \u00a0 | ||||
| Financial assets | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Cash and cash equivalents | \u00a0 | $ | 221,666 | \u00a0 | \u00a0 | $ | \u2014 | \u00a0 | \u00a0 | $ | \u2014 | \u00a0 | \u00a0 | $ | 221,666 | \u00a0 |
| Marketable securities | \u00a0 | \u00a0 | 34,697 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | 34,697 | \u00a0 |
| Equity investments measured at fair value | \u00a0 | \u00a0 | 909 | \u00a0 | \u00a0 | \u00a0 | 1,063 | \u00a0 | \u00a0 | \u00a0 | 8,160 | \u00a0 | \u00a0 | \u00a0 | 10,132 | \u00a0 |
| Financial liabilities | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Warrant liability | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | (1,092 | ) | \u00a0 | \u00a0 | (1,092 | ) |
| Contingent consideration | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | (15,000 | ) | \u00a0 | \u00a0 | (15,000 | ) |
| Total recurring fair value measurements | \u00a0 | $ | 257,272 | \u00a0 | \u00a0 | $ | 1,063 | \u00a0 | \u00a0 | $ | (7,932 | ) | \u00a0 | $ | 250,403 | \u00a0 |
\u00a0
\nThe Company\u2019s financial assets and liabilities required to be measured on a recurring basis are its equity investments measured at fair value, digital assets, acquisition-related contingent consideration, and warrant liability.
\n\u00a0
\nDuring the\u00a0three months ended August 31, 2025, the Company purchased\u00a09.16 units of Bitcoin. Digital assets recorded\u00a0at fair value have quoted prices in active markets for identical assets and are classified as Level\u00a01. The following table presents the Company\u2019s\u00a0digital asset holdings as of August 31, 2025:
\n\u00a0
\n \n| \u00a0 | \u00a0 | Quantity | \u00a0 | \u00a0 | Cost Basis | \u00a0 | \u00a0 | Fair Value | \u00a0 | \u00a0 | Cumulative Unrealized Gain (Loss) | \u00a0 | ||||
| Bitcoin | \u00a0 | \u00a0 | 9.16 | \u00a0 | \u00a0 | $ | 1,000 | \u00a0 | \u00a0 | $ | 992 | \u00a0 | \u00a0 | $ | (8 | ) |
| Total digital assets | \u00a0 | \u00a0 | 9.16 | \u00a0 | \u00a0 | $ | 1,000 | \u00a0 | \u00a0 | $ | 992 | \u00a0 | \u00a0 | $ | (8 | ) |
\u00a0
\nCertain equity investments recorded at fair value have quoted prices in active markets for identical assets and are classified as Level\u00a01. The\u00a0Company classified securities with observable inputs as Level\u00a02\u00a0and without a quoted market price as Level\u00a03.
\n\u00a0
\nThe warrants associated with the warrant liability are classified as Level\u00a03\u00a0derivatives. Consequently, the estimated fair value of the warrant liability is determined using the Black-Scholes pricing model. Until the warrants are exercised, expire, or other facts and circumstances lead the warrant liability to be reclassified to stockholders\u2019 equity, the warrant liability (which relates to warrants to purchase shares of Common Stock) is marked-to-market each reporting period with the change in fair value recorded as the\u00a0change in fair value of warrant liability within the consolidated statements of loss and comprehensive loss. Any significant adjustments to the unobservable inputs disclosed in the table below would have a direct impact on the fair value of the warrant liability.
\n\u00a0
\nA portion of the consideration to be paid in connection with the Company\u2019s acquisition\u00a0of Montauk Brewing Company (\u201cMontauk\u201d) is contingent upon the achievement of certain financial measures as of December 2025. If achieved, such contingent consideration is payable in cash.\u00a0\u00a0During the three months ended August 31, 2025,\u00a0the contingent consideration amount\u00a0was estimated by applying a\u00a0probability of achievement of 0% on the $15,000 sales earn-out component and 0% on the remaining criteria, which is not expected to be achieved\u00a0and as such resulted in a corresponding change\u00a0in fair value of $15,000 for\u00a0the contingent consideration liability recognized.\u00a0During the three months\u00a0ended\u00a0 August 31, 2024, the contingent consideration amount\u00a0was estimated by applying a\u00a0probability of achievement of\u00a0100% on the $15,000\u00a0sales earn-out component and\u00a00% on the remaining criterion, which is\u00a0not\u00a0expected to be achieved. The unobservable inputs into the future expected cash outflows result in a fair value measurement classified as Level\u00a03.\u00a0
\n\u00a0
\nThe balances of assets and liabilities categorized within Level\u00a03\u00a0of the fair value hierarchy measured at fair value on a recurring basis are reconciled, as follows for the period\u00a0ended\u00a0 August 31, 2025:
\n\u00a0
\n \n \n \n| \u00a0 | \u00a0 | Equity | \u00a0 | \u00a0 | Warrant | \u00a0 | \u00a0 | Contingent | \u00a0 | |||
| \u00a0 | \u00a0 | Investments | \u00a0 | \u00a0 | Liability | \u00a0 | \u00a0 | Consideration | \u00a0 | |||
| Balance, May 31, 2025 | \u00a0 | $ | 8,160 | \u00a0 | \u00a0 | $ | (1,092 | ) | \u00a0 | $ | (15,000 | ) |
| Unrealized gain (loss) on fair value | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | (3,670 | ) | \u00a0 | \u00a0 | 15,000 | \u00a0 |
| Balance, August 31, 2025 | \u00a0 | $ | 8,160 | \u00a0 | \u00a0 | $ | (4,762 | ) | \u00a0 | $ | \u2014 | \u00a0 |
\u00a0
\nThe balances of assets and liabilities categorized within Level\u00a03\u00a0of the fair value hierarchy measured at fair value on a recurring basis are reconciled, as follows for the period\u00a0ended\u00a0 August 31, 2024:
\n\u00a0
\n \n| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | APHA 24 | \u00a0 | |
| \u00a0 | \u00a0 | Convertible | \u00a0 | \u00a0 | Equity | \u00a0 | \u00a0 | Warrant | \u00a0 | \u00a0 | Contingent | \u00a0 | \u00a0 | Convertible | \u00a0 | |||||
| \u00a0 | \u00a0 | notes receivable | \u00a0 | \u00a0 | Investments | \u00a0 | \u00a0 | Liability | \u00a0 | \u00a0 | Consideration | \u00a0 | \u00a0 | Debt | \u00a0 | |||||
| Balance, May 31, 2024 | \u00a0 | $ | 32,000 | \u00a0 | \u00a0 | $ | 5,500 | \u00a0 | \u00a0 | $ | (3,253 | ) | \u00a0 | $ | (15,000 | ) | \u00a0 | $ | (330 | ) |
| Additions/(Repayments) | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | 330 | \u00a0 |
| Unrealized gain (loss) on fair value | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | 696 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 |
| Balance, August 31, 2024 | \u00a0 | $ | 32,000 | \u00a0 | \u00a0 | $ | 5,500 | \u00a0 | \u00a0 | $ | (2,557 | ) | \u00a0 | $ | (15,000 | ) | \u00a0 | $ | \u2014 | \u00a0 |
\u00a0
\nThe unrealized gain (loss) on fair value for the convertible debenture, the warrant liability, contingent consideration, and debt securities classified under available-for-sale method is recognized in the consolidated statements of loss and comprehensive loss using the following inputs:
\n\u00a0
\n \n| \u00a0 | \u00a0 | \u00a0 | \u00a0 | Significant | \u00a0 | \u00a0 | |
| \u00a0 | \u00a0 | Valuation | \u00a0 | unobservable | \u00a0 | \u00a0 | \u00a0 |
| Financial asset / financial liability | \u00a0 | technique | \u00a0 | input | \u00a0 | Inputs | \u00a0 |
| Warrant liability | \u00a0 | Black-Scholes | \u00a0 | Volatility, | \u00a0 | 50% | \u00a0 |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | expected life (in years) | \u00a0 | 0.05 | \u00a0 |
| Contingent consideration | \u00a0 | Discounted cash flows | \u00a0 | Probability of achievement | \u00a0 | 0% | \u00a0 |
| Equity investments | \u00a0 | Discounted cash flows | \u00a0 | Probability of achievement | \u00a0 | 70% | \u00a0 |
\u00a0
\nItems measured at fair value on a non-recurring basis
\n\u00a0
\nThe Company's prepaids and other current assets, long lived assets, including property and equipment, goodwill and intangible assets are measured at fair value when there is an indicator of impairment and are recorded at fair value only when an impairment charge is recognized.
\n\u00a0
\nManagement reviews its capital management approach on an ongoing basis and believes that this approach, given the relative size of the Company, is reasonable. There have been no changes to the Company\u2019s capital management approach in the period. The Company considers its cash and cash equivalents and marketable securities as capital.
\n\u00a0
\n "}]},{"name":"rpt:f-1071","factDimensions":{"xbrl:concept":"us-gaap:LongtermDebtPercentageBearingFixedInterestAmount","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","us-gaap:LongtermDebtTypeAxis":"tlry:LongtermDebtExcludingConvertibleDebenturesMember"},"factValues":[{"value":"2437000","decimals":-3}]},{"name":"rpt:f-1072","factDimensions":{"xbrl:concept":"us-gaap:LongtermDebtPercentageBearingFixedInterestAmount","xbrl:period":"2024-06-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","us-gaap:LongtermDebtTypeAxis":"tlry:LongtermDebtExcludingConvertibleDebenturesMember"},"factValues":[{"value":"2546000","decimals":-3}]},{"name":"rpt:f-1073","factDimensions":{"xbrl:concept":"us-gaap:ConvertibleDebt","xbrl:period":"2025-09-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","us-gaap:LongtermDebtTypeAxis":"us-gaap:ConvertibleDebtMember"},"factValues":[{"value":"100000000","decimals":-8}]},{"name":"rpt:f-1074","factDimensions":{"xbrl:concept":"us-gaap:ConvertibleDebt","xbrl:period":"2024-06-01T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","us-gaap:LongtermDebtTypeAxis":"us-gaap:ConvertibleDebtMember"},"factValues":[{"value":"105000000","decimals":-6}]},{"name":"rpt:f-1075","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | August 31, | \u00a0 | |
| \u00a0 | \u00a0 | Level 1 | \u00a0 | \u00a0 | Level 2 | \u00a0 | \u00a0 | Level 3 | \u00a0 | \u00a0 | 2025 | \u00a0 | ||||
| Financial assets | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Cash and cash equivalents | \u00a0 | $ | 264,828 | \u00a0 | \u00a0 | $ | \u2014 | \u00a0 | \u00a0 | $ | \u2014 | \u00a0 | \u00a0 | $ | 264,828 | \u00a0 |
| Equity investments measured at fair value | \u00a0 | \u00a0 | 995 | \u00a0 | \u00a0 | \u00a0 | 1,017 | \u00a0 | \u00a0 | \u00a0 | 8,160 | \u00a0 | \u00a0 | \u00a0 | 10,172 | \u00a0 |
| Digital assets | \u00a0 | \u00a0 | 992 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | 992 | \u00a0 |
| Financial liabilities | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Warrant liability | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | (4,762 | ) | \u00a0 | \u00a0 | (4,762 | ) |
| Contingent consideration | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 |
| Total recurring fair value measurements | \u00a0 | $ | 266,815 | \u00a0 | \u00a0 | $ | 1,017 | \u00a0 | \u00a0 | $ | 3,398 | \u00a0 | \u00a0 | $ | 271,230 | \u00a0 |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | May 31, | \u00a0 | |
| \u00a0 | \u00a0 | Level 1 | \u00a0 | \u00a0 | Level 2 | \u00a0 | \u00a0 | Level 3 | \u00a0 | \u00a0 | 2025 | \u00a0 | ||||
| Financial assets | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Cash and cash equivalents | \u00a0 | $ | 221,666 | \u00a0 | \u00a0 | $ | \u2014 | \u00a0 | \u00a0 | $ | \u2014 | \u00a0 | \u00a0 | $ | 221,666 | \u00a0 |
| Marketable securities | \u00a0 | \u00a0 | 34,697 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | 34,697 | \u00a0 |
| Equity investments measured at fair value | \u00a0 | \u00a0 | 909 | \u00a0 | \u00a0 | \u00a0 | 1,063 | \u00a0 | \u00a0 | \u00a0 | 8,160 | \u00a0 | \u00a0 | \u00a0 | 10,132 | \u00a0 |
| Financial liabilities | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Warrant liability | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | (1,092 | ) | \u00a0 | \u00a0 | (1,092 | ) |
| Contingent consideration | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | (15,000 | ) | \u00a0 | \u00a0 | (15,000 | ) |
| Total recurring fair value measurements | \u00a0 | $ | 257,272 | \u00a0 | \u00a0 | $ | 1,063 | \u00a0 | \u00a0 | $ | (7,932 | ) | \u00a0 | $ | 250,403 | \u00a0 |
| \u00a0 | \u00a0 | Quantity | \u00a0 | \u00a0 | Cost Basis | \u00a0 | \u00a0 | Fair Value | \u00a0 | \u00a0 | Cumulative Unrealized Gain (Loss) | \u00a0 | ||||
| Bitcoin | \u00a0 | \u00a0 | 9.16 | \u00a0 | \u00a0 | $ | 1,000 | \u00a0 | \u00a0 | $ | 992 | \u00a0 | \u00a0 | $ | (8 | ) |
| Total digital assets | \u00a0 | \u00a0 | 9.16 | \u00a0 | \u00a0 | $ | 1,000 | \u00a0 | \u00a0 | $ | 992 | \u00a0 | \u00a0 | $ | (8 | ) |
| \u00a0 | \u00a0 | Equity | \u00a0 | \u00a0 | Warrant | \u00a0 | \u00a0 | Contingent | \u00a0 | |||
| \u00a0 | \u00a0 | Investments | \u00a0 | \u00a0 | Liability | \u00a0 | \u00a0 | Consideration | \u00a0 | |||
| Balance, May 31, 2025 | \u00a0 | $ | 8,160 | \u00a0 | \u00a0 | $ | (1,092 | ) | \u00a0 | $ | (15,000 | ) |
| Unrealized gain (loss) on fair value | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | (3,670 | ) | \u00a0 | \u00a0 | 15,000 | \u00a0 |
| Balance, August 31, 2025 | \u00a0 | $ | 8,160 | \u00a0 | \u00a0 | $ | (4,762 | ) | \u00a0 | $ | \u2014 | \u00a0 |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | APHA 24 | \u00a0 | |
| \u00a0 | \u00a0 | Convertible | \u00a0 | \u00a0 | Equity | \u00a0 | \u00a0 | Warrant | \u00a0 | \u00a0 | Contingent | \u00a0 | \u00a0 | Convertible | \u00a0 | |||||
| \u00a0 | \u00a0 | notes receivable | \u00a0 | \u00a0 | Investments | \u00a0 | \u00a0 | Liability | \u00a0 | \u00a0 | Consideration | \u00a0 | \u00a0 | Debt | \u00a0 | |||||
| Balance, May 31, 2024 | \u00a0 | $ | 32,000 | \u00a0 | \u00a0 | $ | 5,500 | \u00a0 | \u00a0 | $ | (3,253 | ) | \u00a0 | $ | (15,000 | ) | \u00a0 | $ | (330 | ) |
| Additions/(Repayments) | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | 330 | \u00a0 |
| Unrealized gain (loss) on fair value | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | 696 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 | \u00a0 | \u00a0 | \u2014 | \u00a0 |
| Balance, August 31, 2024 | \u00a0 | $ | 32,000 | \u00a0 | \u00a0 | $ | 5,500 | \u00a0 | \u00a0 | $ | (2,557 | ) | \u00a0 | $ | (15,000 | ) | \u00a0 | $ | \u2014 | \u00a0 |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | Significant | \u00a0 | \u00a0 | |
| \u00a0 | \u00a0 | Valuation | \u00a0 | unobservable | \u00a0 | \u00a0 | \u00a0 |
| Financial asset / financial liability | \u00a0 | technique | \u00a0 | input | \u00a0 | Inputs | \u00a0 |
| Warrant liability | \u00a0 | Black-Scholes | \u00a0 | Volatility, | \u00a0 | 50% | \u00a0 |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | expected life (in years) | \u00a0 | 0.05 | \u00a0 |
| Contingent consideration | \u00a0 | Discounted cash flows | \u00a0 | Probability of achievement | \u00a0 | 0% | \u00a0 |
| Equity investments | \u00a0 | Discounted cash flows | \u00a0 | Probability of achievement | \u00a0 | 70% | \u00a0 |
Note 25. Segment reporting
\n\u00a0
\nOur Company\u2019s Chief Operating Decision Maker (\u201cCODM\u201d) is the Chairman of the Board of Directors and Chief Executive Officer. The\u00a0CODM uses segment gross profit for the purpose of resource allocation, assessment of segment performance against determined targets, and in deciding whether to implement cost saving targets. The Company operates in\u00a0\u00a0segments.\u00a01) cannabis operations, which encompasses the production, distribution,\u00a0sale, co-manufacturing and advisory services of both medical and adult-use cannabis, as well as, produce operations which are managed by the cannabis team,\u00a02) beverage operations, which encompasses the production, marketing and sale of beverage products,\u00a03) distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers, and\u00a04) wellness products, which encompasses wellness and better-for-you foods and beverages. This structure is in line with how our CODM assesses our performance and allocates resources.
\n\u00a0
\nOperating segments have\u00a0not\u00a0been aggregated and\u00a0no\u00a0asset information is provided for the segments because the Company\u2019s CODM does\u00a0not\u00a0receive asset information by segment on a regular basis.
\n\u00a0
\nThe following tables reconcile the Company\u2019s segment gross profit\u00a0to consolidated U.S. GAAP results:
\n\u00a0
\n \n \n \n| \u00a0 | \n\u00a0 | \n For the three months ended | \n \u00a0 | \n|||||
| \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n||
| \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n\u00a0 | \n 2024 | \n \u00a0 | \n||
| Beverage | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Net beverage revenue | \n \u00a0 | \n$ | \n55,739 | \n\u00a0 | \n\u00a0 | \n$ | \n55,972 | \n\u00a0 | \n
| Beverage costs | \n \u00a0 | \n\u00a0 | \n34,413 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n33,050 | \n\u00a0 | \n
| Beverage gross profit | \n \u00a0 | \n\u00a0 | \n21,326 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n22,922 | \n\u00a0 | \n
| Cannabis | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Net cannabis revenue | \n \u00a0 | \n\u00a0 | \n64,511 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n61,249 | \n\u00a0 | \n
| Cannabis costs | \n \u00a0 | \n\u00a0 | \n41,241 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n37,054 | \n\u00a0 | \n
| Cannabis gross profit | \n \u00a0 | \n\u00a0 | \n23,270 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n24,195 | \n\u00a0 | \n
| Distribution | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Distribution revenue | \n \u00a0 | \n\u00a0 | \n74,007 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n68,071 | \n\u00a0 | \n
| Distribution costs | \n \u00a0 | \n\u00a0 | \n66,008 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n60,138 | \n\u00a0 | \n
| Distribution gross profit | \n \u00a0 | \n\u00a0 | \n7,999 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n7,933 | \n\u00a0 | \n
| Wellness | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Wellness revenue | \n \u00a0 | \n\u00a0 | \n15,244 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n14,752 | \n\u00a0 | \n
| Wellness costs | \n \u00a0 | \n\u00a0 | \n10,370 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n10,096 | \n\u00a0 | \n
| Wellness gross profit | \n \u00a0 | \n\u00a0 | \n4,874 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n4,656 | \n\u00a0 | \n
| Total | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Total revenue | \n \u00a0 | \n\u00a0 | \n209,501 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n200,044 | \n\u00a0 | \n
| Total costs | \n \u00a0 | \n\u00a0 | \n152,032 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n140,338 | \n\u00a0 | \n
| Total gross profit | \n \u00a0 | \n$ | \n57,469 | \n\u00a0 | \n\u00a0 | \n$ | \n59,706 | \n\u00a0 | \n
\u00a0
\nSegment costs are comprised of cost of goods sold, which include product costs, salaries and an allocation of overhead costs.\u00a0
\n\u00a0
\nThe following table reconciles the total segment gross profit\u00a0to the Company\u2019s consolidated totals:
\n\u00a0
\n\u00a0
\n \n| \u00a0 | \u00a0 | For the three months ended | \u00a0 | |||||
| \u00a0 | \u00a0 | August 31, | \u00a0 | \u00a0 | August 31, | \u00a0 | ||
| \u00a0 | \u00a0 | 2025 | \u00a0 | \u00a0 | 2024 | \u00a0 | ||
| Gross profit | \u00a0 | $ | 57,469 | \u00a0 | \u00a0 | $ | 59,706 | \u00a0 |
| Operating expenses: | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| General and administrative | \u00a0 | \u00a0 | 41,053 | \u00a0 | \u00a0 | \u00a0 | 44,113 | \u00a0 |
| Selling | \u00a0 | \u00a0 | 12,923 | \u00a0 | \u00a0 | \u00a0 | 11,690 | \u00a0 |
| Amortization | \u00a0 | \u00a0 | 3,929 | \u00a0 | \u00a0 | \u00a0 | 21,804 | \u00a0 |
| Marketing and promotion | \u00a0 | \u00a0 | 10,155 | \u00a0 | \u00a0 | \u00a0 | 11,566 | \u00a0 |
| Research and development | \u00a0 | \u00a0 | 41 | \u00a0 | \u00a0 | \u00a0 | 105 | \u00a0 |
| Change in fair value of contingent consideration | \u00a0 | \u00a0 | (15,000 | ) | \u00a0 | \u00a0 | \u2014 | \u00a0 |
| Litigation costs, net of recoveries | \u00a0 | \u00a0 | 1,007 | \u00a0 | \u00a0 | \u00a0 | 1,595 | \u00a0 |
| Restructuring costs | \u00a0 | \u00a0 | 869 | \u00a0 | \u00a0 | \u00a0 | 4,247 | \u00a0 |
| Transaction costs (income), net | \u00a0 | \u00a0 | 400 | \u00a0 | \u00a0 | \u00a0 | 1,156 | \u00a0 |
| Total operating expenses | \u00a0 | \u00a0 | 55,377 | \u00a0 | \u00a0 | \u00a0 | 96,276 | \u00a0 |
| Operating income (loss) | \u00a0 | \u00a0 | 2,092 | \u00a0 | \u00a0 | \u00a0 | (36,570 | ) |
| Interest expense, net | \u00a0 | \u00a0 | (6,696 | ) | \u00a0 | \u00a0 | (9,842 | ) |
| Non-operating income (expense), net | \u00a0 | \u00a0 | 3,832 | \u00a0 | \u00a0 | \u00a0 | 12,646 | \u00a0 |
| Loss before income taxes | \u00a0 | \u00a0 | (772 | ) | \u00a0 | \u00a0 | (33,766 | ) |
| Income tax expense (recovery), net | \u00a0 | \u00a0 | (2,285 | ) | \u00a0 | \u00a0 | 886 | \u00a0 |
| Net income (loss) | \u00a0 | $ | 1,513 | \u00a0 | \u00a0 | $ | (34,652 | ) |
\u00a0
\nChannels of Cannabis revenue were as follows:
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \n For the three months ended | \n \u00a0 | \n|||||
| \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n||
| \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n\u00a0 | \n 2024 | \n \u00a0 | \n||
| Revenue from Canadian medical cannabis | \n \u00a0 | \n$ | \n6,146 | \n\u00a0 | \n\u00a0 | \n$ | \n6,261 | \n\u00a0 | \n
| Revenue from Canadian adult-use cannabis | \n \u00a0 | \n\u00a0 | \n64,067 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n57,235 | \n\u00a0 | \n
| Revenue from wholesale cannabis | \n \u00a0 | \n\u00a0 | \n4,155 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n5,507 | \n\u00a0 | \n
| Revenue from international cannabis | \n \u00a0 | \n\u00a0 | \n13,367 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n12,191 | \n\u00a0 | \n
| Less excise taxes | \n \u00a0 | \n\u00a0 | \n(23,224 | \n) | \n\u00a0 | \n\u00a0 | \n(19,945 | \n) | \n
| Total | \n \u00a0 | \n$ | \n64,511 | \n\u00a0 | \n\u00a0 | \n$ | \n61,249 | \n\u00a0 | \n
\u00a0
\n \n \nGeographic net revenue:
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \n For the three months ended | \n \u00a0 | \n|||||
| \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n||
| \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n\u00a0 | \n 2024 | \n \u00a0 | \n||
| USA | \n \u00a0 | \n$ | \n63,961 | \n\u00a0 | \n\u00a0 | \n$ | \n63,880 | \n\u00a0 | \n
| Canada | \n \u00a0 | \n\u00a0 | \n58,167 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n55,905 | \n\u00a0 | \n
| EMEA | \n \u00a0 | \n\u00a0 | \n85,253 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n77,672 | \n\u00a0 | \n
| Rest of World | \n \u00a0 | \n\u00a0 | \n2,120 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n2,587 | \n\u00a0 | \n
| Total | \n \u00a0 | \n$ | \n209,501 | \n\u00a0 | \n\u00a0 | \n$ | \n200,044 | \n\u00a0 | \n
\u00a0
\nGeographic capital assets:
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \nAugust 31, | \n\u00a0 | \n\u00a0 | \nMay 31, | \n\u00a0 | \n||
| \u00a0 | \n\u00a0 | \n2025 | \n\u00a0 | \n\u00a0 | \n2025 | \n\u00a0 | \n||
| USA | \n \u00a0 | \n$ | \n195,436 | \n\u00a0 | \n\u00a0 | \n$ | \n200,003 | \n\u00a0 | \n
| Canada | \n \u00a0 | \n\u00a0 | \n262,114 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n267,458 | \n\u00a0 | \n
| EMEA | \n \u00a0 | \n\u00a0 | \n99,109 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n97,371 | \n\u00a0 | \n
| Rest of World | \n \u00a0 | \n\u00a0 | \n3,498 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n3,601 | \n\u00a0 | \n
| Total | \n \u00a0 | \n$ | \n560,157 | \n\u00a0 | \n\u00a0 | \n$ | \n568,433 | \n\u00a0 | \n
\u00a0
\nMajor customers are defined as customers that are materially significant\u00a0to the Company\u2019s annual revenues. For the three months ended August 31, 2025 and 2024, there were major customers representing a material contribution\u00a0to\u00a0our quarterly revenues.
\n "}]},{"name":"rpt:f-1175","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n| \u00a0 | \n\u00a0 | \n For the three months ended | \n \u00a0 | \n|||||
| \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n||
| \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n\u00a0 | \n 2024 | \n \u00a0 | \n||
| Beverage | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Net beverage revenue | \n \u00a0 | \n$ | \n55,739 | \n\u00a0 | \n\u00a0 | \n$ | \n55,972 | \n\u00a0 | \n
| Beverage costs | \n \u00a0 | \n\u00a0 | \n34,413 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n33,050 | \n\u00a0 | \n
| Beverage gross profit | \n \u00a0 | \n\u00a0 | \n21,326 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n22,922 | \n\u00a0 | \n
| Cannabis | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Net cannabis revenue | \n \u00a0 | \n\u00a0 | \n64,511 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n61,249 | \n\u00a0 | \n
| Cannabis costs | \n \u00a0 | \n\u00a0 | \n41,241 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n37,054 | \n\u00a0 | \n
| Cannabis gross profit | \n \u00a0 | \n\u00a0 | \n23,270 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n24,195 | \n\u00a0 | \n
| Distribution | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Distribution revenue | \n \u00a0 | \n\u00a0 | \n74,007 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n68,071 | \n\u00a0 | \n
| Distribution costs | \n \u00a0 | \n\u00a0 | \n66,008 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n60,138 | \n\u00a0 | \n
| Distribution gross profit | \n \u00a0 | \n\u00a0 | \n7,999 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n7,933 | \n\u00a0 | \n
| Wellness | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Wellness revenue | \n \u00a0 | \n\u00a0 | \n15,244 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n14,752 | \n\u00a0 | \n
| Wellness costs | \n \u00a0 | \n\u00a0 | \n10,370 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n10,096 | \n\u00a0 | \n
| Wellness gross profit | \n \u00a0 | \n\u00a0 | \n4,874 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n4,656 | \n\u00a0 | \n
| Total | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Total revenue | \n \u00a0 | \n\u00a0 | \n209,501 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n200,044 | \n\u00a0 | \n
| Total costs | \n \u00a0 | \n\u00a0 | \n152,032 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n140,338 | \n\u00a0 | \n
| Total gross profit | \n \u00a0 | \n$ | \n57,469 | \n\u00a0 | \n\u00a0 | \n$ | \n59,706 | \n\u00a0 | \n
| \u00a0 | \u00a0 | For the three months ended | \u00a0 | |||||
| \u00a0 | \u00a0 | August 31, | \u00a0 | \u00a0 | August 31, | \u00a0 | ||
| \u00a0 | \u00a0 | 2025 | \u00a0 | \u00a0 | 2024 | \u00a0 | ||
| Gross profit | \u00a0 | $ | 57,469 | \u00a0 | \u00a0 | $ | 59,706 | \u00a0 |
| Operating expenses: | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| General and administrative | \u00a0 | \u00a0 | 41,053 | \u00a0 | \u00a0 | \u00a0 | 44,113 | \u00a0 |
| Selling | \u00a0 | \u00a0 | 12,923 | \u00a0 | \u00a0 | \u00a0 | 11,690 | \u00a0 |
| Amortization | \u00a0 | \u00a0 | 3,929 | \u00a0 | \u00a0 | \u00a0 | 21,804 | \u00a0 |
| Marketing and promotion | \u00a0 | \u00a0 | 10,155 | \u00a0 | \u00a0 | \u00a0 | 11,566 | \u00a0 |
| Research and development | \u00a0 | \u00a0 | 41 | \u00a0 | \u00a0 | \u00a0 | 105 | \u00a0 |
| Change in fair value of contingent consideration | \u00a0 | \u00a0 | (15,000 | ) | \u00a0 | \u00a0 | \u2014 | \u00a0 |
| Litigation costs, net of recoveries | \u00a0 | \u00a0 | 1,007 | \u00a0 | \u00a0 | \u00a0 | 1,595 | \u00a0 |
| Restructuring costs | \u00a0 | \u00a0 | 869 | \u00a0 | \u00a0 | \u00a0 | 4,247 | \u00a0 |
| Transaction costs (income), net | \u00a0 | \u00a0 | 400 | \u00a0 | \u00a0 | \u00a0 | 1,156 | \u00a0 |
| Total operating expenses | \u00a0 | \u00a0 | 55,377 | \u00a0 | \u00a0 | \u00a0 | 96,276 | \u00a0 |
| Operating income (loss) | \u00a0 | \u00a0 | 2,092 | \u00a0 | \u00a0 | \u00a0 | (36,570 | ) |
| Interest expense, net | \u00a0 | \u00a0 | (6,696 | ) | \u00a0 | \u00a0 | (9,842 | ) |
| Non-operating income (expense), net | \u00a0 | \u00a0 | 3,832 | \u00a0 | \u00a0 | \u00a0 | 12,646 | \u00a0 |
| Loss before income taxes | \u00a0 | \u00a0 | (772 | ) | \u00a0 | \u00a0 | (33,766 | ) |
| Income tax expense (recovery), net | \u00a0 | \u00a0 | (2,285 | ) | \u00a0 | \u00a0 | 886 | \u00a0 |
| Net income (loss) | \u00a0 | $ | 1,513 | \u00a0 | \u00a0 | $ | (34,652 | ) |
| \u00a0 | \n\u00a0 | \n For the three months ended | \n \u00a0 | \n|||||
| \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n||
| \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n\u00a0 | \n 2024 | \n \u00a0 | \n||
| Revenue from Canadian medical cannabis | \n \u00a0 | \n$ | \n6,146 | \n\u00a0 | \n\u00a0 | \n$ | \n6,261 | \n\u00a0 | \n
| Revenue from Canadian adult-use cannabis | \n \u00a0 | \n\u00a0 | \n64,067 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n57,235 | \n\u00a0 | \n
| Revenue from wholesale cannabis | \n \u00a0 | \n\u00a0 | \n4,155 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n5,507 | \n\u00a0 | \n
| Revenue from international cannabis | \n \u00a0 | \n\u00a0 | \n13,367 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n12,191 | \n\u00a0 | \n
| Less excise taxes | \n \u00a0 | \n\u00a0 | \n(23,224 | \n) | \n\u00a0 | \n\u00a0 | \n(19,945 | \n) | \n
| Total | \n \u00a0 | \n$ | \n64,511 | \n\u00a0 | \n\u00a0 | \n$ | \n61,249 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n For the three months ended | \n \u00a0 | \n|||||
| \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n\u00a0 | \n August 31, | \n \u00a0 | \n||
| \u00a0 | \n\u00a0 | \n 2025 | \n \u00a0 | \n\u00a0 | \n 2024 | \n \u00a0 | \n||
| USA | \n \u00a0 | \n$ | \n63,961 | \n\u00a0 | \n\u00a0 | \n$ | \n63,880 | \n\u00a0 | \n
| Canada | \n \u00a0 | \n\u00a0 | \n58,167 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n55,905 | \n\u00a0 | \n
| EMEA | \n \u00a0 | \n\u00a0 | \n85,253 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n77,672 | \n\u00a0 | \n
| Rest of World | \n \u00a0 | \n\u00a0 | \n2,120 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n2,587 | \n\u00a0 | \n
| Total | \n \u00a0 | \n$ | \n209,501 | \n\u00a0 | \n\u00a0 | \n$ | \n200,044 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \nAugust 31, | \n\u00a0 | \n\u00a0 | \nMay 31, | \n\u00a0 | \n||
| \u00a0 | \n\u00a0 | \n2025 | \n\u00a0 | \n\u00a0 | \n2025 | \n\u00a0 | \n||
| USA | \n \u00a0 | \n$ | \n195,436 | \n\u00a0 | \n\u00a0 | \n$ | \n200,003 | \n\u00a0 | \n
| Canada | \n \u00a0 | \n\u00a0 | \n262,114 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n267,458 | \n\u00a0 | \n
| EMEA | \n \u00a0 | \n\u00a0 | \n99,109 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n97,371 | \n\u00a0 | \n
| Rest of World | \n \u00a0 | \n\u00a0 | \n3,498 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n3,601 | \n\u00a0 | \n
| Total | \n \u00a0 | \n$ | \n560,157 | \n\u00a0 | \n\u00a0 | \n$ | \n568,433 | \n\u00a0 | \n
Note 26. Subsequent Events
\n\u00a0
\nBetween September 5\u00a0and 15, 2025, certain holders elected to exercise an aggregate of 6,209,000 of the Company\u2019s issued and outstanding warrants in accordance with their terms.\u00a0 Pursuant to the exercise of such warrants, Tilray received \u00a0of cash consideration and delivered 6,209,000 shares of common stock to such holders.
\n\u00a0
\nOn October 9, 2025, Tilray entered into an assignment and assumption agreement with\u00a0Double Diamond\u00a0Holdings Ltd. (\u201cDDH\u201d), an Ontario corporation, pursuant to which, among other things, Tilray acquired from DDH a promissory note in the amount of $14,821 (the \u201cNote\u201d) payable by Aphria Diamond Inc. (\u201cAphria Diamond\u201d). DDH is a joint venturer with Aphria Inc. (Tilray\u2019s wholly-owned subsidiary) in Aphria Diamond. As consideration for the Note, Tilray issued 8,617,068 shares of its Common Stock to DDH.
\n\u00a0
\n \n \n "}]},{"name":"rpt:f-1275","factDimensions":{"xbrl:concept":"tlry:ClassOfWarrantOrRightExercised","xbrl:period":"2025-09-05T00:00:00/2025-09-16T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares","us-gaap:ClassOfWarrantOrRightAxis":"tlry:WarrantsMember","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember"},"factValues":[{"value":"6209000"}]},{"name":"rpt:f-1276","factDimensions":{"xbrl:concept":"tlry:StockIssuedDuringPeriodSharesWarrantsExercised","xbrl:period":"2025-09-05T00:00:00/2025-09-16T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares","us-gaap:ClassOfWarrantOrRightAxis":"tlry:WarrantsMember","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember"},"factValues":[{"value":"6209000"}]},{"name":"rpt:f-1277","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentFaceAmount","xbrl:period":"2025-10-10T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"iso4217:USD","us-gaap:DebtInstrumentAxis":"tlry:PromissoryNoteMember","dei:LegalEntityAxis":"tlry:AphriaDiamondMember","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember"},"factValues":[{"value":"14821000","decimals":-3}]},{"name":"rpt:f-1278","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesNewIssues","xbrl:period":"2025-10-09T00:00:00/2025-10-10T00:00:00","xbrl:entity":"cik:0001731348","xbrl:unit":"xbrla:shares","srt:CounterpartyNameAxis":"tlry:DoubleDiamondHoldingsLtdMember","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember"},"factValues":[{"value":"8617068"}]},{"name":"rpt:f-1279","factDimensions":{"xbrl:concept":"ecd:MtrlTermsOfTrdArrTextBlock","xbrl:period":"2025-06-01T00:00:00/2025-09-01T00:00:00","xbrl:entity":"cik:0001731348"},"factValues":[{"value":" \n \n\u00a0
\nOn October 7, 2025, the Company entered into Amendment No. 1 (the \u201cAmendment\u201d), to the Employment Agreement, originally dated July 27, 2021, with its Chief Executive Officer, Irwin D. Simon (the \u201cExecutive\u201d). The Amendment modifies certain compensation benefit provisions.\u00a0 Effective as of the start of the Company\u2019s Fiscal Year 2026, the Company will pay the Executive (i) an after-tax amount equal to $5,000 per month for participation in all employee retirement and welfare benefit plans and (ii) an additional $500 per month as a car allowance.\u00a0 The foregoing summary does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, which is filed as Exhibit 10.2\u00a0to this Quarterly Report on Form 10-Q.
\n\u00a0
\nOn October 9, 2025, Tilray entered into an assignment and assumption agreement with\u00a0Double Diamond\u00a0Holdings Ltd. (\u201cDDH\u201d), an Ontario corporation, pursuant to which, among other things, Tilray acquired from DDH a promissory note in the amount of $14,821,356 (the \u201cNote\u201d) payable by Aphria Diamond Inc. (\u201cAphria Diamond\u201d). DDH is a joint venturer with Aphria Inc. (Tilray\u2019s wholly-owned subsidiary) in Aphria Diamond. As consideration for the Note, Tilray issued 8,617,068 shares of its Common Stock to DDH.\u00a0 DDH\u2019s management team provides a range of additional services to the Company at no incremental cost. These additional services include expert advice on maximizing vegetable cultivation and cannabis yields\u00a0for the Company\u2019s Quebec cultivation facility; maximizing cultivation yields for the Company\u2019s Cayuga outdoor grow\u00a0facility; and cannabis cultivation insights for the Company\u2019s facility in Cantanhede, Portugal.
\n\u00a0
\nThe consideration shares were issued to DDH in reliance on the exemption provided by Regulation S (\u201cRegulation S\u201d) of the Securities Act of 1933, as amended (the \u201cSecurities Act\u201d), which permits offers or sales of securities by Tilray outside of the United States that are not made to \u201cU.S. Persons\u201d or for the account or benefit of a \u201cU.S. Person\u201d, as that term is defined in Rule 902 of Regulation S.\u00a0 No underwriter participated in the offer and sale of the consideration shares, and no commission or other remuneration was paid or given directly or indirectly in connection therewith.
\n\u00a0
\n \n \n "}]}]}}